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Abstract 
Non-apoptotic plasma membrane blebbing occurs during cell motility and tumor spread in 
several human malignancies. Bleb dynamics are regulated through rearrangement of the cortical 
actin cytoskeleton and its associated proteins. Our previous studies reported the importance of 
plasma membrane blebbing by the formin mDia1 in providing the driving force for entotic 
invasion of one cell into its neighbouring cell. Entosis is a form of homotypic cell-in-cell invasion, 
in which low cellular adhesion induces ROCK- and actomyosin-dependent invasion. The 
physiological consequences of this process are not well-understood. Entotic invasion has been 
suggested to induce tumor promoting effects, while other studies supported a tumor suppressor 
role. Although the molecular requirements and actin-binding proteins controlling bleb dynamics 
are well characterized, the importance of a potential transcriptional regulation underlying 
sustained, long-term blebbing as observed during cancer cell or entotic invasion has not been 
studied. Given the direct association between the Serum Response Factor (SRF) coactivator 
Myocardin-Related Transcription Factor (MRTF-A) and actin dynamics, we addressed the impact 
of the MRTF/SRF transcriptional pathway for plasma membrane blebbing and bleb-associated 
entotic invasion. In this study, we find that cortical contractility during plasma membrane 
blebbing is tightly associated to dynamic MRTF cytoplasmic-nuclear shuttling. Our findings 
reveal that not only the dynamics of plasma membrane blebs depend on MRTF/SRF, but also 
entotic invasion. Interestingly, we found that MRTF/SRF-dependent upregulation of the 
metastasis associated ERM protein Ezrin is fundamental for non-apoptotic blebbing and entotic 
invasion. Thus, our results highlight a novel mechanism, by which the actin-dependent 
transcription factor MRTF controls Ezrin expression to facilitate bleb-associated invasive 
motility. These findings may have important implications in understanding invasive motility as 
well as for future concepts targeting metastasis. 
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Zusammenfassung 
 
Nicht-apoptotische Plasmamembranausstülpungen können während der Zellmotilität und der 
Dissemination von Tumoren im Rahmen vieler Erkrankungen auftreten. Dabei ist die Dynamik 
einer Plasmamembranausstülpung durch Umgestaltung des kortikalen Aktinzytoskelett sowie 
der assoziierten Proteine reguliert. Unsere vorhergehenden Arbeiten stellten über das Formin 
mDia1-vermittelte Plasmamembranausstülpungen als treibende Kraft der entotischen, 
homotyptischen Zell-in-Zell-Invasion heraus, wobei eine geringe Adhäsion diese ROCK- und 
aktomyosin-abhängige Form der Zell-in-Zell-Invasion förderte. Die physiologischen 
Konsequenzen der entotischen Zell-in-Zell-Invasion sind nicht hinreichend geklärt, da neben 
tumor-fördernden auch inhibierende Effekte publiziert wurden. Obwohl die generellen, 
molekularen Grundlagen und aktin-bindenden Proteine für Plasmamembranausstülpungen 
weitestgehend bekannt sind, ist eine potentielle Regulation der Genexpression bei lang-
andauernden Plasmamembranausstülpungen, welche bei Krebszell- oder entotischer Zell-in-
Zell-Invasion beobachtet wurden, nicht aufgeklärt.  Aufgrund der direkten Interaktion zwischen 
dem Ko-Aktivator des Serum Response Factors (SRF), nämlich Myocardin-Related Transcription 
Factor (MRTF-A) und Aktindynamik haben wir die Bedeutung der MRTF/SRF-gesteuerten 
Genregulation für Plasmamembranausstülpungen und die assoziierte, entotische Zell-in-Zell-
Invasion untersucht. Wir zeigen in dieser Arbeit, dass die kortikale Kontraktilität während der 
Plasmamembranausstülpungen eng mit der dynamischen, zytoplasmatisch-nukleären 
Translokation von MRTF korreliert. Unsere Ergebnisse veranschaulichen weiterhin, dass nicht 
nur die Dynamik von Plasmamembranausstülpungen, sondern auch die entotische Zell-in-Zell-
Invasion von MRTF/SRF abhängig ist. Wir fanden interessanterweise eine Notwendigkeit der 
MRTF/SRF-abhängigen Steigerung der Genexpression des mit Metastasen-assoziierten ERM-
Proteins Ezrin für nicht-apoptotische Plasmamembranausstülpungen und entotische Zell-in-Zell-
Invasion. Daher erschließt sich aus unseren Ergebnissen ein neuartiger Mechanismus, bei dem 
der aktin-abhängige Transkriptionsfaktor MRTF die Genexpression von Ezrin kontrolliert, um 
invasive, mit Plasmamembranausstülpungen-assoziierte Zellmotilität zu steuern. Dies hat 
Auswirkungen auf das allgemeine Verständnis der invasiven Zellmotilität und liefert unter 
Umständen neue Konzepte für die Therapie von Metastasen. 
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1. Introduction 
1.1. Cancer cell invasion 
Tumor progression is a multistep process for cancer cells during which they acquire different 
characteristics, which enable them to survive, proliferate and disseminate. These characteristics 
are defined as hallmarks of cancer.  
The fundamental hallmarks of cancer that enable tumor growth and metastatic dissemination 
include sustaining proliferative signaling, evading growth suppressors, avoiding immune 
destruction, enabling replicative immortality, tumor promoting inflammation, activation of 
tissue invasion and metastasis, inducing sustained angiogenesis, genome instability and 
mutation, resisting cell death evading apoptosis and deregulating cellular energetics (Figure 1). 
The tumor microenvironment and its signaling interactions within different cancer phenotypes 
further influence tumor cell behaviour (Hanahan and Weinberg 2011).  
 
 
Figure 1: The hallmarks of cancer. The hallmarks of cancer define the essential alterations in cell 
physiology and different capabilities that cells acquire during tumor progression. This image was adapted 
from (Hanahan and Weinberg 2011).  
The most critical feature of cancer is sustained chronic proliferation due to activation of signaling 
pathways by different mechanisms. An increase in cell proliferation will result in tumor growth, 
which in turn can trigger cell senescence and apoptosis. Accordingly, cancer cells negatively 
regulate the action of tumor suppressor genes to overcome senescence or apoptosis. A loss of 
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cell-cell contact inhibition further increases cell proliferation and impairs normal tissue 
homeostasis in cancer cells (Hanahan and Weinberg 2011).  
It has been observed that cancer cells undergo programmed cell death by apoptosis, a process 
which becomes increasingly debilitated during tumor progression. In contrast to apoptosis, 
another form of programmed cell death is necrosis, whereby cells release proinflammatory 
signals into the tissue microenvironment triggering tumor-promoting factors to enhance 
angiogenesis, cell proliferation and invasiveness. In addition, other emerging hallmarks of cancer 
are the ability to reprogram cellular metabolism to support proliferation and the avoidance of 
immunological destruction. Interestingly, genomic instability and mutability in cancer cell, as 
well as tumor promoting inflammation by innate immune cells, are two features that drive 
tumor progression and facilitate acquisition of other hallmarks (Hanahan and Weinberg 2011).  
Cancer cells can acquire multiple features leading to invasion and metastasis, in which one of 
the crucial steps is the regulation of signaling pathways allowing alteration of gene expression 
to mediate actin cytoskeleton dynamics (M. F. Olson and Sahai 2009). Furthermore, activation 
of signaling pathways promotes malignancy inducing cellular programs, such as epithelial-to-
mesenchymal transition (EMT), which activates tissue invasion and metastasis (Hanahan and 
Weinberg 2011). 
1.1.1. Modes of cancer cell invasion 
Neoplastic diseases are characterized by high levels of metastatic dissemination, in which cancer 
cell migration is important to understand the invasiveness and metastasis of tumor cells 
(Hanahan and Weinberg 2011).  Metastasis is the spread of cancer cells from the primary tumor 
site into other organs, known as the metastatic cascade. This multistep process defined by 
physiological changes in cells begins with cell motility and invasion into the surrounding tissue, 
followed by intravasation into the blood or lymphatic vessels, a transit through the vessels, and 
ultimately extravasation from the vessels into other tissues generating micro-metastasis or new 
site colonizations (Figure 2) (Sahai 2007; Sanz-Moreno and Marshall 2010).  
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Figure 2: The metastatic process. Primary tumor cells invade into the tissue environment, then undergo 
dissemination and intravasation into blood or lymphatic vessels. These tumor cells transit via the blood 
stream and subsequently get either arrested as emboli in narrow vessels or attached to the vessel wall. 
The latter is followed by cancer cell extravasation, which results either in apoptosis, dormancy or can lead 
to tumor cell proliferation and the formation of metastasis. The image was adapted from (Sahai 2007). 
Cell migration and invasion are essential for the metastatic dissemination of cancer cells. Here, 
metastatic cancer cells undergo molecular and cellular changes involving remodelling of the 
extracellular matrix (ECM) and the actin cytoskeleton. This process can be studied either in 
isolated cells moving across the ECM on two dimensional (2D) surfaces or under physiological 
conditions using mammalian cells migrating in three dimensional (3D) tissues. Accordingly, their 
cell motility and actin-mediated protrusions within the ECM can diverge depending on whether 
migration occurs in 2D or 3D. Although actomyosin-mediated protrusions and cell contractility 
are important for all migration types, the distinct biophysical traits are dependent on the 
migration mode. Moreover, some cell migration modes require pericellular proteolysis, which 
triggers ECM degradation and realignment during cell movement. Cell migration in 3D ECM is 
described by five different steps, initiated by the action of an external stimulus which results in 
I) the protrusion of an actin-driven leading pseudopod, followed by II) adhesion of the leading 
edge to the ECM and consequently force generation towards the ECM to get realigned, then III) 
recruitment of proteases (MMPs) to allow proteolysis at the leading edge and ECM remodelling, 
which results in IV) actomyosin cell contraction promoting V) rear-end retraction and forward 
movement. Thus, proteolytic cell migration is a mechanism dependent on the ECM and the cell 
type (Figure 3) (Friedl and Wolf 2009; A. J. Ridley 2003; Wolf et al. 2007). 
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Figure 3: The five steps of cell migration. Cell migration requires the coordination of several cellular 
processes which can be divided into five steps: 1) actin-driven leading-edge protrusion; 2) adhesion and 
force generation phase by formation of integrin-mediated interactions to the substrate; 3) matrix 
disruption; 4) actomyosin cell contraction that leads to 5) rear-end retraction and forward sliding of the 
cell. This image was modified from (Friedl and Wolf 2009).  
Cancer cells have the ability to adapt to different environmental conditions by switching their 
migration strategies (Sahai 2005). Tumor cells can migrate by undergoing either individual or 
collective modes of cancer cell invasion (Figure 5) in response to the tissue environment and the 
extracellular matrix through changes in the dynamic organization of the cytoskeleton (Friedl and 
Wolf 2010). Cancer cells migrate individually using different mechanisms such as the spike-
mediated, the elongated-mesenchymal or the bleb-dependent rounded amoeboid mode of 
migration. Cells undergoing collective migration move as multicellular streams, small clusters via 
tumor buds or as large clusters dependent on cell-cell junctions (Friedl and Alexander 2011; 
Pandya, Orgaz, and Sanz-Moreno 2017). This thesis is focused on the bleb-associated mode of 
invasion, thereby it is crucial to understand invasion of individual cancer cells.  
1.1.2. The amoeboid and the mesenchymal motility modes 
Individual migrating cells, such as the melanoma cell line A375-M2, are able to undergo two 
different modes of tumor cell invasion: amoeboid, rounded bleb-associated motility and 
elongated-mesenchymal cell motility (Figure 4). Several studies have reported that the GTPase 
RhoA promotes rounded bleb-dependent cell motility, while the elongated mode of cell motility 
is associated with the GTPase Rac-1 (Sahai and Marshall 2003).  
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The main phenotypic characteristics of the mesenchymal and amoeboid modes of invasiveness 
are shown in (Figure 4). The protease-dependent mesenchymal type of invasion is defined by 
elongated cell morphology, low cell motility speed, the formation of actin-rich protrusions such 
as filopodia or lamellipodia, and high catalytic activity as a result of Matrix Metalloproteinases 
(MMPs) recruited to the integrin-ECM binding site. Unlike mesenchymal cells, the protease-
independent amoeboid invasion mode is determined by rounded cell morphology, the 
formation of actin-driven bleb protrusions and high cell motility speed due to a lack of tight cell-
ECM adhesion (Sahai and Marshall 2003; Paňková et al. 2010; Sahai 2005). Interestingly, the 
blebby mode of motility requires the ERM protein Ezrin at the cell rear to drive polarized invasion 
(Lorentzen et al. 2011). Importantly, amoeboid invasion is driven by Rho-ROCK signaling, which 
enhances actomyosin contractility by increasing phosphorylation of MLC2 (Friedl and Wolf 
2010). 
 
 
Figure 4: Cell plasticity during Amoeboid-Mesenchymal Transition. Cell motility of individual cells can be 
either mesenchymal-elongated or the amoeboid blebbing type. Amoeboid motility is defined by a round 
morphology, dependent on actomyosin contractility and does not involve ECM adhesion or degradation. 
In addition, these migrating cells produce plasma membrane blebs during motility. In contrast, 
mesenchymal motility is Rac-dependent, whereas cells show an elongated morphology and present MMP-
mediated ECM degradation (Gandalovičová et al. 2016).  
Matrix Metalloproteinases (MMPs) are enzymes with high proteolytic activity which degrade 
components of the ECM and are known to play an important role in matrix degradation in cancer 
cell motility (Wolf et al. 2003). Consistent with this, specific MMPs have been identified to be 
upregulated in different tumors (Lubbe et al. 2006; Poola et al. 2005). Recent studies have 
revealed that MMP9 can control cancer amoeboid migration in a catalytic-independent manner 
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by enhancing actomyosin contractility and increasing MLC2 phosphorylation to produce 
sustained blebbing for amoeboid invasion (Orgaz et al. 2014). 
Plasticity or interconversion between these two cell motility modes has been described. For 
instance, silencing of DOCK10, a GEF specific for Cdc42, in melanoma cells was shown to 
promote elongated mesenchymal migration via the amoeboid to mesenchymal transition 
(AMT). This was associated with a decrease in actomyosin contractility as a result of reduced 
Rho activation and with reduced MLC2 phosphorylation (Gadea et al. 2008). Consistently, 
melanoma A375-M2 cells undergo an amoeboid to mesenchymal transition in a similar manner 
upon treatment with the ROCK inhibitor Y-27632 (Gadea et al. 2008). Alternatively, other studies 
have also demonstrated that mechanisms such as Rac inactivation induce a transition from 
mesenchymal mode to amoeboid motility (MAT) (Sanz-Moreno et al. 2008). 
 
1.1.3. The role of tumor cell plasticity 
Certain cell types are able to use different modes of motility and undergo transitions between 
them, a process also known as tumor cell plasticity (Figure 5). These transitions require 
phenotypical adaptation of the motile cells in response to the microenvironment. The ability of 
cells to switch between modes of invasion is controlled by the actin cytoskeleton and the 
extracellular matrix (ECM), and involves several factors such as actomyosin contractility, Rho 
signaling and the formation of actin-rich protrusions (Paňková et al. 2010; Friedl and Wolf 2010). 
Cell plasticity allows cells to undergo mesenchymal to amoeboid transition (MAT) and amoeboid 
to mesenchymal transition (AMT) as an adaptive response to the environment. These modes of 
invasion are interconvertible (Figure 5) and for instance, mesenchymal to amoeboid transition 
can be induced in cancer cells by reducing the concentration of fibers in the ECM. This results in 
a weakness of cell-ECM adhesion enhancing activation of the Rho signaling pathway and 
increasing actomyosin contractility (Sahai and Marshall 2003). In addition, MAT is induced in 
cancer cells by blocking key invasion components such as MMPs (Wolf et al. 2003). Unlike MAT, 
the underlying mechanisms driving the amoeboid-mesenchymal transition (AMT) include 
inhibition of Rho signaling, abrogation of pericellular proteolysis and weakening of cell-ECM 
adhesions. Moreover, epithelial cancer cells can undergo a transition from collective invasion to 
motile individual cells, known as the epithelial-mesenchymal-transition (EMT) as a result of 
impaired cell-cell junctions caused by alterations in gene transcription (Friedl and Wolf 2003; 
Gandalovičová et al. 2016).  
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Dynamic rearrangement of the actin cytoskeleton is required for cell motility and invasion, and 
the molecular mechanisms and signaling involved are crucial for understanding these processes. 
Hence, the next chapter will focus on the actin cytoskeleton and its role in cellular functions.  
 
 
Figure 5: Mechanisms of cancer cell motility. This model shows the plasticity between the different 
modes of cancer cell migration. The latter can occur individually or collectively. Migratory plasticity allows 
interconversion between the different invasion modes, which are characterized by the cell morphology 
and regulated by different molecular mechanisms. When cell-cell junctions remain, cells undergo the 
collective invasion moving as multicellular streams, budding or large clusters. Alternatively, cells using the 
individual mode of invasion can use different protrusion-based mechanisms such as the elongated-
mesenchymal or the bleb-dependent rounded amoeboid mode. Alteration of different parameters can 
lead to plasticity and conversion from one migration mode to another. This image was taken from (Friedl 
and Wolf 2010). 
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1.2. The role of the actin cytoskeleton  
The actin cytoskeleton is an important network of filaments and regulatory proteins that is 
crucial for cell shape, migration, cytokinesis and intracellular transport (Fletcher and Mullins 
2010). 
Eukaryotic cells have three different types of filaments: actin filaments, microtubules and 
intermediate filaments. Actin filaments are the thinnest filaments of the cytoskeleton with a 
diameter of 6-8 nm (Heath and Dunn 1978), and its network is modulated by dynamic actin 
polymerization and depolymerization (Bugyi and Carlier 2010). 
1.2.1. Introduction to actin 
Actin is found in two different forms, globular monomeric actin (G-actin) and filamentous actin 
(F-actin). Actin is a 42 kDa protein and its filaments are organized in double helical structures. 
Actin filaments can cooperate with bundling proteins to generate mechanical functions, 
including cell motility, cell shape, cell adhesion and transcription (Tseng et al. 2005), which are 
regulated through changes between monomeric and filamentous actin (Pollard and Cooper 
2009). Actin polymerization occurs when G-actin assembles into actin filaments (Holmes et al. 
1990), and the constant process of actin polymerization at the plus end (or also called barbed 
end) and simultaneous depolymerization at the minus end (or also called pointed end) is known 
as actin treadmilling (Figure 6) (Pollard and Borisy 2003). 
Actin treadmilling which is also called “head to tail polymerization” is controlled through ATP 
hydrolysis (Wegner 1976), and plays an important role in driving cell motility (Small 1995; Bugyi 
and Carlier 2010). The regulation of ATP hydrolysis and ADP to ATP exchange are crucial for the 
speed of the actin treadmill (Pollard and Borisy 2003). ATP-bound G-actin is incorporated at the 
plus end of the filament and the bound ATP gets hydrolysed to ADP after polymerization. Then, 
ADP-bound G-actin located at the minus end of the filament readily disassembles (Figure 6) (Le 
and Carlier 2008; Dominguez and Holmes 2011).  
Actin filament formation and its dynamics are highly regulated processes, not only by the 
regulation of ATP hydrolysis, but also by the action of several actin binding proteins (ABPs) 
(Figure 6). These include the capping proteins that control filament assembly and disassembly. 
Gelsolin binds at the plus end of F-actin to prevent polymerization (Kim, Cooper, and Sept 2010), 
tropomodulin binds at the plus end to block actin association (Yamashiro et al. 2012) and profilin 
binds to ATP bound G-actin, thereby promoting actin polymerization (Pring, Weber, and Bubb 
1992). Additionally, actin treadmilling is also modulated in response to extracellular and 
intracellular signals in conjunction with Rho-GTPases.  
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Figure 6: Regulation of actin treadmilling. Actin monomers polymerize into double-helical filaments. 
Profilin forms a complex with ATP-bound G-actin, which is preferentially added to the barbed end of the 
filament. Upon hydrolysis of the ATP to ADP, the filament is destabilized while the pointed end associates 
with actin-depolymerizing factors (ADFs). This leads to depolymerization of F-actin at the pointed end to 
free ADP-bound G-actin. As a result, nucleotide exchange recycles ADP-G-actin to ATP-G-actin, which can 
again be bound to profilin to restart the actin treadmill (Le and Carlier 2008).  
Given that spontaneous polymerization of actin dimers or trimers is energetically unfavourable 
and to maintain an equilibrium between assembly and disassembly of actin filaments at steady 
state, additional factors called nucleation promoting factors (NPFs) are required for de novo 
actin filament formation (Pollard and Cooper 2009). Actin nucleating factors can be divided into 
three classes: 1) the Arp2/3 (actin-related protein 2/3) complex, 2) the tandem monomer-
binding nucleators like Spire and 3) the formins. This latter family is defined by a conserved 
formin homology 2 domain and, in particular, the diaphanous subfamiliy (mDia) will be 
addressed in this study. These are fundamental regulators of the formation of actin structures 
such as lamellipodia, filopodia and bleb protrusions, which are essential for biological functions 
such as cell migration, cytokinesis, cell adhesion and morphogenesis (Bugyi and Carlier 2010; 
Chesarone, DuPage, and Goode 2010).  
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1.2.2. Organization of the actin cytoskeleton during cell processes 
The dynamic actin cytoskeleton plays an important role for many physiological and pathological 
functions. Actin is responsible not only for the formation of membrane protrusions at the 
leading edge, including cellular extensions like lamellipodia, filopodia, microvilli, ruffles (Chhabra 
and Higgs 2007), but also other membranes protrusions, such as podosomes (Gimona et al. 
2008) and membrane blebs (Fackler and Grosse 2008). These actin-driven structures are 
important controlling directionality in cells cultured in 2D and 3D environments (Nürnberg, 
Kitzing, and Grosse 2011). Furthermore, organization of actin filaments defines the cellular 
phenotype modulated through Rho-GTPases. For instance, filopodia protrusions are mainly 
regulated by Cdc42, lamellipodia protrusions are Rac-dependent, while bleb protrusions are 
Rho-dependent (Lehtimaki, Hakala, and Lappalainen 2017). 
Actin structures are relevant for a wide variety of cellular processes including, among others, 
cytokinesis (Glotzer 2001), cell adhesion (Adams 2004), endocytosis (Kaksonen, Toret, and 
Drubin 2006), cell shape (Pollard and Cooper 2009), cell migration (M. F. Olson and Sahai 2009) 
and cell polarity (Dominguez and Holmes 2011).  
The dynamic organization of the actin cytoskeleton is critical for cell migration in development 
and disease. For example, cell migration is necessary for gastrulation in zebrafish germ cells, 
while neoplastic diseases are characterized by high levels of metastatic cell migration. Thus, cell 
migration and motility of cells are fundamental to understand invasiveness and metastasis of 
tumor cells. Actin polymerization takes place at the cell front leading to the formation of actin 
structures, whereas Rho-ROCK-mediated actomyosin contractility occurs at the rear edge of the 
cell providing actin-dependent force generation to drive cell motility (Anne J. Ridley 2011; 
Lehtimaki, Hakala, and Lappalainen 2017). 
Invasive cell migration requires actin assembly, which is the essential driving force to generate 
protrusive membrane structures such as plasma membrane blebs, invadopodia or pseudopodia 
(Figure 7). Besides the rearrangement of the actin cytoskeleton is critical for structures like 
invadopodia and lamellipodia, some evidence has shown that bleb-dependent invasion is the 
most efficient way of migration and requires less energy than the lamellipodium or filopodia-
mediated motility  (G. Charras and Paluch 2008). Consistent with this, the work presented in this 
thesis is focused on bleb structures, which are known to regulate migration and invasion in 
invasive cancer cell phenotypes. Additionally, plasma membrane blebs are regulated through 
the actomyosin cortex, which will be addressed in the following chapters. 
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Figure 7: Protrusive actin-driven structures in cancer cell invasion. Cancer cell invasion phenotypes 
require the rearrangement of the actin cytoskeleton, which in turn involves the formation of different 
actin-driven protrusions, such as plasma membrane blebs, invadopodia or pseudopodia. The image was 
taken from (Nürnberg, Kitzing, and Grosse 2011). 
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1.3. Plasma membrane blebbing 
Plasma membrane (PM) blebbing is required for cell motility during tumor cell invasion and 
metastasis (Sahai and Marshall 2003; Madsen et al. 2015). Cancer cells can move generating 
different actin-rich plasma membrane protrusions, such as lamellipodia and filopodia when 
cultured on rigid matrix or generating membrane blebs in 3D extracellular matrix (M. Bergert et 
al. 2012).  
1.3.1. Plasma membrane bleb structures 
Cellular blebs, first described as bubbles (Holtfreter 1943), are spherical membrane protrusions 
generated by changes in hydrostatic pressure at the contractile cell cortex (Cunningham et al. 
1992). These structures are highly dynamic actin-regulated cell protrusions as a result of 
membrane detachment from the actin cell cortex (Guillaume T Charras et al. 2006) involved in 
common physiological features from different cellular processes, including cell motility, 
apoptosis, cell spreading, cell migration and cytokinesis (Fackler and Grosse 2008). In addition, 
blebs are actin-driven structures observed in different cell types such as zebrafish germ cells, 
ameba, parasites, bacteria, fibroblasts, endothelial cells, mesenchymal cells, immune cells and 
tumor cells (Sanz-Moreno et al. 2008; Blaser et al. 2006; Norman, Sengupta, and Aranda-
Espinoza 2011; Laster and Mackenzie 1996; Loitto et al. 2002; Ruprecht et al. 2015; Tournaviti 
et al. 2007; Angus et al. 2008).  
These protrusions of the PM can be either reversible (non-apoptotic blebs) or irreversible 
(apoptotic blebs). Apoptotic blebbing during cell death is uniform and leads to cell lysis, whereas 
non-apoptotic prominent blebbing has a polarized distribution allowing cell motility during cell 
migration (G. Charras and Paluch 2008). Both types of blebbing are induced in response to 
different mechanical or chemical stimuli resulting in contraction of the actin cortex and thereby, 
initiating signaling transduction pathways that are regulated by the rearrangements of the actin 
cytoskeleton (Guillaume T Charras et al. 2006). Non-apoptotic blebbing is typically defined by 
the dynamic bleb cycle. 
In general, the bleb cycle is divided in three phases: rapid bleb expansion, a short static phase 
and slower bleb retraction. Disruption of the plasma membrane from the actin cortex is caused 
by an increase of intracellular hydrostatic pressure generating bleb growth. Bleb expansion, 
which usually lasts about 5-30 seconds, is characterized by the protrusion of the plasma 
membrane and the recruitment of the actin-membrane linkers such as ERM proteins and the 
epidermal growth factor Eps8 to the protruding bleb membrane. Blebs can expand up to 2 µm 
from the plasma membrane, until actin reassembly occurs at the bleb cell cortex. As a result, 
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forces derived from actomyosin contractility mediate bleb retraction, which occurs in about 60-
120 seconds (Figure 8) (Guillaume T Charras et al. 2005, 2006, 2008; Aoki et al. 2016).  
 
Figure 8: The life cycle of a plasma membrane bleb. The bleb cycle is initiated by extracellular triggers, 
which results in disruption of the PM-actin cortex leading to an increase of hydrostatic pressure 
generating bleb expansion (1). The protrusion of the plasma membrane is characterized by the 
recruitment of actin-membrane crosslinkers of the ERM family such as Ezrin (2). Then, cortical actin 
assembly takes place during a static phase (3), followed by actomyosin contractility to retract the bleb (4). 
This image was taken from (Fackler and Grosse 2008).  
1.3.2. Actin regulation during PM blebbing 
Plasma membrane blebbing is dependent on the actin cytoskeleton and regulated by different 
factors including actin polymerization, actomyosin contractility, substrate rigidity and the ECM. 
Several studies have reported that Rho-ROCK signaling drives PM blebbing through activation of 
the ERM proteins (G. T. Charras 2008). RhoA activates the actin nucleator mDia1, which is 
essential for membrane blebbing (Thomas M Kitzing et al. 2007; Purvanov et al. 2014). Other 
formins, such as FHOD1 and DIAPH3, have been shown to be recruited to membrane blebs 
(Stastna et al. 2012; Hannemann et al. 2008). Recent studies identified the epidermal growth 
factor receptor kinase substrate 8 (Eps8) together with the Rho family protein Rnd3 as key 
regulators for the formation of bleb structures mediated by Rho-ROCK signaling. When Rnd3 is 
recruited to blebs, RhoA is activated inducing ROCK-dependent phosphorylation of Ezrin. In 
addition, enhancing recruitment of Eps8 to the bleb cortex will lead to bleb retraction through 
myosin activation downstream of RhoA (Aoki et al. 2016).  
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1.4. The actomyosin cell cortex 
The cellular cortex is a thin actomyosin network tightly bound to the plasma membrane which 
controls cell shape changes by the action of cellular mechanics. This actomyosin cortex is 
composed of cortical actin filaments crosslinked with actin-binding proteins (ABP), and 
generates cortical tension to modulate changes in cell shape, which contributes to cell 
migration, morphogenesis, cell division, cell polarization and cell-cell contact formation (Stewart 
et al. 2011; Sedzinski et al. 2011; Levayer and Lecuit 2012; Chugh and Paluch 2018).  
1.4.1. The cell cortex composition  
The cellular actin cortex composition was first evaluated in isolated individual cellular blebs from 
human melanoma M2 cells using mass spectrometry. This study identified several actin-binding 
proteins (ABP) including, among others, actin crosslinkers, nucleators, capping proteins, actin-
membrane linkers, myosin motors, scaffold proteins and contractility regulators (Biro et al. 
2013).  
Actin filament nucleators like formins are found at the cortex where they nucleate and elongate 
actin filaments (Bovellan et al. 2014). Other regulators of actin assembly and disassembly are 
the capping proteins, profilin and cofilin, which act by binding to actin monomers to enhance 
actin polymerization to control cellular processes like cell division. In addition, the actin 
crosslinkers α-actinin, filamin and fascin play a role in organizing actin filaments into networks 
in the cell cortex to regulate actomyosin contractility (Ennomani et al. 2016). Moreover, myosin 
motors are key components providing contractile cortical tension, and together with actin 
crosslinkers and the actin-membrane linkers they control actomyosin contractility within the cell 
cortex (Biro et al. 2013). Importantly, actin-membrane linkers such as myosin and ERM (Ezrin, 
Radixin, Moesin) proteins were shown to be required for the association of the plasma 
membrane (PM) with the underlying cortical actin cytoskeleton and to contribute to PM tension 
(Anthony Bretscher, Edwards, and Fehon 2002; Biro et al. 2013; Diz-Muñoz et al. 2010). 
1.4.2. The ERM proteins 
The Ezrin, Radixin and Moesin (ERM) proteins are an evolutionary conserved group of proteins 
of the FERM superfamily (Sato et al. 1992). The first protein identified was Ezrin (80 kDa) which 
was originally detected at the microvillus cytoskeleton from chicken intestinal epithelial cells (A 
Bretscher 1983). A few years later, Radixin (82 kDa) was purified from cell-cell adherent 
junctions isolated from rat liver (Tsukita, Hieda, and Tsukita 1989). Moesin (78 kDa) was first 
found as a heparin-binding protein isolated from smooth muscle cells in bovine uterus (Lankes 
et al. 1988). 
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This family of actin-membrane linkers are defined by their common N-terminal region, the FERM 
(Four-point-one ERM) domain (Gary and Bretscher 1995). They are essential for many cellular 
processes including signal transduction pathways, cell division (Kunda et al. 2008; McClatchey 
2014), morphogenesis (Crepaldi et al. 1997; Gautreau, Louvard, and Arpin 2000), cell adhesion 
(Takeuchi et al. 1994; Pujuguet et al. 2003), cell migration (Crepaldi et al. 1997; Valderrama, 
Thevapala, and Ridley 2012), and pathological conditions such as cancer cell invasion and 
metastasis (Martin et al. 2003; Mak et al. 2012; Clucas and Valderrama 2015). 
Structurally, these fundamental cell cortex integrators are organized with a N-terminal FERM 
domain containing the F1, F2 and F3 subdomains. The FERM domain is followed by an α-helical 
domain, a linker region and the carboxy-terminal domain known as C-terminal ERM-association 
domain (C-ERMAD), which is able to bind the FERM domain or F-actin depending on the protein 
conformation (Figure 9) (Arpin et al. 2011; Fehon, McClatchey, and Bretscher 2010).  
Originally, the F-actin binding site was identified at the C-terminus of Ezrin in its active state 
(Turunen, Wahlström, and Vaheri 1994). The C-ERMAD domain is bound to the FERM domain in 
the autoinhibited state of Ezrin (Gary and Bretscher 1995). 
 
Figure 9: Domain structure of ERM proteins. ERMs are composed of an N-terminal FERM domain (dark 
blue), which consists of three subdomains: F1, F2 and F3. The FERM domain is followed by an α-helical 
domain (light blue), a linker region and the C-terminal domain called C-ERMAD (yellow), where F-actin 
binding and phosphorylation take place (Arpin et al. 2011; Fehon, McClatchey, and Bretscher 2010). 
1.4.2.1. Regulation and function of ERM proteins 
The function of the ERM proteins is regulated by an open (active) and a closed (inactive) 
conformation. Both structures are controlled via conformational changes resulting from the 
action of phospholipids and kinases (Canals et al. 2010).  
First studies reported that the regulation of ERM proteins is dependent on conformational 
changes, in which the intramolecular association between FERM and C-ERMAD leads to the 
dormant form of the Ezrin protein (Gary and Bretscher 1995). Subsequent studies showed that 
ERM activation is a two-step process with sequential events involving FERM domain recruitment 
to plasma membrane regions rich in Phosphatidylinositol 4,5-bisphosphate (PIP2) (Niggli et al. 
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1995; Hirao et al. 1996), which then triggers phosphorylation of threonine residues at the F-actin 
binding site (Yonemura S, Matsui T 2002). Thus, activated ERMs are associated with the plasma 
membrane bound to membrane proteins through their N-terminal FERM domain and to F-actin 
through the C-terminal C-ERMAD domain (Figure 10). In contrast, inactive ERMs remain in a 
resting state through self-association until the FERM domain initiates its activation by binding 
PIP2 (Fehon, McClatchey, and Bretscher 2010; Anthony Bretscher, Edwards, and Fehon 2002) 
(Figure 10).  
 
 
Figure 10: ERM activation by phosphorylation. ERM proteins are found in two different states, an active 
“open” conformation and a dormant, inactive “closed” conformation. Dormant Ezrin is defined by a direct 
inhibitory association of the FERM and C-ERMAD domain. ERM proteins are activated through PIP2 
binding. Thereby, ERMs are recruited to the plasma membrane leading to subsequent phosphorylation at 
T567 by Rho-kinase or PKC, which reduces the affinity of the FERM for the C-ERMAD domain. This allows 
them to bind transmembrane receptors linking the actin cortex to the plasma membrane and initiating 
different signaling transduction pathways (Fehon, McClatchey, and Bretscher 2010; Anthony Bretscher, 
Edwards, and Fehon 2002). 
Hence, ERM phosphorylation is a key process controlling the regulation and activation of these 
actin-membrane linkers proteins. The first identification of the phosphorylation sites regulating 
ERMs was at the threonine 558 (T558) in Moesin upon platelet activation (Nakamura, Amieva, 
and Furthmayr 1995). Later on, studies revealed that phosphorylation of the corresponding 
threonine in Ezrin and Radixin reduces the affinity of the C-ERMAD for the FERM domain (Matsui 
et al. 1998). Accordingly, expression of the phosphomimetic threonine residue T567D 
(constitutively active form) shows a remarkably reduction in the oligomerization of Ezrin at the 
plasma membrane (Fievet et al. 2004). Alternatively, expression of the non-phosphorylatable 
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T567A Ezrin (inactive form) is found to be poorly associated with the actin cytoskeleton 
(Gautreau, Louvard, and Arpin 2000).  
Several kinases have been reported to phosphorylate the conserved threonine residues: Rho-
associated kinase (ROCK) (Matsui et al. 1998), protein kinase Cα (PKCα) (Ng et al. 2001), PKCθ 
(Pietromonaco et al. 1998), G-protein coupled receptor kinase 2 (Cant and Pitcher 2005), Nck-
interacting kinase (Baumgartner et al. 2006), Lymphocyte-oriented kinase (LOK) (Belkina et al. 
2009) and MST4 (ten Klooster et al. 2009). Activated ERM proteins bind several transmembrane 
receptors through their FERM domain via direct association with cytoplasmic tails of receptor 
tyrosine kinases (RTKs) and growth factor receptors (Crepaldi et al. 1997; Reczek, Berryman, and 
Bretscher 1997). ERM proteins also associate with co-receptors like CD44 for directional cell 
motility (Legg et al. 2002) or with the Intercellular Adhesion Molecule-2 (ICAM-2) for 
recruitment by natural killer cells (Helander et al. 1996). 
Even though these proteins are known to interact with transmembrane receptors upon ERM 
activation, they are consequently involved in signal-transduction pathways by association with 
signaling molecules, for instance the RhoA signaling pathway. RhoA, a GTPase, is a key regulator 
of the cortical actin cytoskeleton and previous work has shown the importance of ERMs as RhoA 
downstream effectors mediating cytoskeletal rearrangements (Hirao et al. 1996; Mackay et al. 
1997). Interestingly, ERM proteins have also been reported to play a crucial role upstream of the 
RhoA pathway (Hatzoglou et al. 2007). Therefore, ERM proteins regulate Rho-signal 
transduction pathways.  
ERM proteins are involved in regulating diverse cell functions through reorganization of the 
cytoskeleton during development and differentiation. These include stable maintenance of 
oocyte polarity, allowing mitotic rounding and spindle orientation during cell division, driving 
epithelial morphogenesis and apical surface formation, controlling cell-cell junction assembly 
and playing a role during podocyte formation (Fehon, McClatchey, and Bretscher 2010; Arpin et 
al. 2011; McClatchey 2014). Besides the broad functions of ERMs during development, further 
studies have also shown their pivotal role in physiology and disease. For instance, these proteins 
participate in cancer progression, metastasis, melanoma cell migration, leukocyte adhesion, B 
cell activation and the formation of the immunological synapse (Pore and Gupta 2015; Clucas 
and Valderrama 2015; Lorentzen et al. 2011). 
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Activation of Moesin (the only ERM in Drosophila) in Drosophila S2 cells is crucial for cortical 
stability, microtubule organization and spindle morphogenesis during mitosis (Kunda et al. 2008; 
Carreno et al. 2008), whereas in mammalian cells activation of ERM proteins is essential for a 
functional spindle orientation during mitosis (Machicoane et al. 2014). 
Several studies provided evidence for the crucial role of ERMs in plasma membrane protrusions. 
Moesin and Ezrin are required for efficient bleb retraction (Guillaume T Charras et al. 2006). 
Consistent with this, ERM proteins are known to be essential at the actin cortex for plasma 
membrane attachment and bleb-based cell migration (Paluch and Raz 2013). However, 
interfering with ERM activity decreases membrane to cortex attachment, which in turn increases 
the proportion of cellular blebs and triggers a reduction in the directionality of migrating cells in 
zebrafish during gastrulation (Diz-Muñoz et al. 2010). Alternatively, increased overall ERM 
activity is associated with reduced cell blebbing in melanoma cells, mast cells and zebrafish germ 
cells (Lorentzen et al. 2011; Paluch and Raz 2013).  
1.4.3. Ezrin and its role in cell invasion 
Although ERM proteins have been reported to be involved in several cellular processes, 
alteration of their physiological expression level might lead to aberrant gene expression 
enhancing cancer progression through the metastatic cascade. Consistently, Ezrin has been 
identified as a metastasis-associated protein and therefore plays a crucial role during cancer 
progression (Clucas and Valderrama 2015). However, the mechanisms by which Ezrin 
contributes to a metastatic phenotype still remain unclear. Since then, understanding the role 
of Ezrin in cancer cell invasion has been an emerging topic.  
Overexpression of Ezrin has been related to an increase in metastatic potential in different 
tumor entities, such as osteosarcoma (Ren et al. 2009), breast cancer (Elliott et al. 2005), lung 
cancer (Deng et al. 2007), pancreatic cancer (Meng et al. 2010), hepatocellular cancer (Kang et 
al. 2010), colorectal adenocarcinoma (Patara et al. 2011), prostate cancer (Y-C Chuan et al. 2010) 
and melanoma (Federici et al. 2009). In addition, a tissue microarray immunohistochemistry 
study supported a role for Ezrin expression in a wide number of human cancers (Bruce et al. 
2007).  
Interestingly, several studies revealed that Ezrin is implicated in tumor metastasis. For instance, 
mutation of the tyrosine Y477 leads to reduced cell migration and tumor invasion in breast 
carcinoma cells (Debnath and Brugge 2005; Mak et al. 2012). This suggests an important role for 
Y477, which is phosphorylated by Src in the regulation of tumor invasion and metastasis. 
Therefore indicates that the Src-Ezrin pathway may be a potential prognostic marker for human 
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breast cancer (Srivastava et al. 2005; Mak et al. 2012). In breast cancer cell lines, silencing of 
Ezrin resulted in decreased cell invasion in non-invasive MCF10A and metastatic MDA-MB-231 
cells (Konstantinovsky, Davidson, and Reich 2012). Ezrin expression levels increase from benign 
to malignant breast cancers (Gschwantler-Kaulich et al. 2013). Furthermore, the well-known 
tumor suppressor gene BRCA1 is associated with ERMs at the plasma membrane and controls 
cell spreading and motility of breast cancer cells via ubiquitin ligase activity (Figure 11) (Coene 
et al. 2011). Other features like abnormal Ezrin distribution are also associated with invasive 
breast carcinomas (Sarrió et al. 2006). In addition, Ezrin localization switches from the apical 
membrane to the cytoplasm in lung cancer cells, and Ezrin expression was notably increased in 
highly metastatic lung cancer cell lines (Li et al. 2012). These findings suggest that Ezrin 
localization is fundamental for its activation leading to signal transduction pathways regulating 
cancer progression (Figure 11). 
 
Figure 11: Ezrin in cancer progression. This cartoon illustrates the oncogenic potential of Ezrin in epithelial 
cells. Ezrin overexpression increases survival of cancer cells, thereby allowing invasion into other tissues, 
and interferes with cell-cell contacts. Additionally, Ezrin is upregulated in a Myc-dependent manner and 
downregulated by the tumor suppressor BRCA1. This image was adapted from (Clucas and Valderrama 
2015).  
A recent study has identified a mechanism by which Dsg3 regulates the transcriptional factor 
AP-1 and PKC through Ezrin phosphorylation in cancer cell invasion (Figure 11) (Brown et al. 
2014). A role for Ezrin in cell adhesion has been determined where it controls E-cadherin-
dependent adherens junctions through Rac-1 activation (Pujuguet et al. 2003). Moreover, loss 
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of E-cadherin function enhances tumor progression (Canel et al. 2013), which it is regulated by 
Ezrin (Figure 11).  
Ezrin also plays a role in prostate cancer. Depletion of Ezrin or overexpression of the T567A 
dominant-negative mutant resulted in reduced androgen-mediated prostate cancer invasion 
(Yin-Choy Chuan et al. 2006), indicating the importance of Ezrin phosphorylation and its 
correlation with tumor invasiveness. Importantly, early studies already highlighted that Ezrin 
activation is essential for transformation, in particular overexpression of the mutant T567A 
inhibited cell transformation by the DbI and Net oncogenes (Tran Quang et al. 2000). Consistent 
with this, an increase of Ezrin expression in prostate cancer is associated with higher expression 
of the Myc oncogene. Further studies showed that Ezrin regulates Myc through the PI3K/Akt 
pathway, which in turn is essential for cancer cell invasion (Y-C Chuan et al. 2010). These data 
supported the notion that Myc-dependent effects leading to Ezrin overexpression are mediated 
by the PI3K/Akt pathway (Figure 11). Together, Ezrin has multiple effects on tumor metastasis, 
including adhesion, tumor extravasation and invasiveness. Thus, Ezrin has emerged as a 
potential therapeutic target for cancer therapy. 
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1.5. Entosis 
Entosis is a cell-in-cell phenomenon that has been observed in several human malignancies, for 
instance in pleural exudates from metastatic breast cancer. Entosis is defined by homotypic cell-
in-cell invasion, in which one cell actively invades into a neighbouring cell where it undergoes 
non-apoptotic cell death (Overholtzer et al. 2007). A recent study reported that non-apoptotic 
plasma membrane blebbing together with polarized actin dynamics are the driving force for 
entotic invasion in MCF10A cells (Figure 12) (Purvanov et al. 2014). 
Cell-in-cell structures are found in many human tumors including breast carcinoma, melanoma, 
pancreatic carcinoma, cervical carcinoma, liver carcinoma, urothelial carcinoma, stomach 
carcinoma or colon carcinoma, but also among non-invasive epithelial cells (Overholtzer and 
Brugge 2008). Thus, entosis is prevalent in cancer and like matrix detachment, anchorage 
independence, aberrant proliferation or metabolic stress represents a hallmark feature of 
cancer cells (Hanahan and Weinberg 2011).  
 
Figure 12: PM-blebbing provides the driving force for entotic invasion. This time series shows MCF10A 
cells in suspension undergoing entosis. A blebby cell stably expressing LifeAct-GFP to label the actin 
cytoskeleton invades into another non-blebbing cell expressing LifeAct-mCherry. Actin is enriched at the 
uropod-like structure at the rear end of the invading cell, which provides the driving force for invasion. 
This image was adapted from (Purvanov et al. 2014).  
Entosis was described as an integrin-independent process that can be triggered by extracellular 
matrix detachment under conditions of low adhesion (Overholtzer et al. 2007). However, recent 
studies revealed additional triggers for entotic cell-in-cell invasion in adherent epithelial cells. 
For example, nutrient starvation can induce entosis in adherent cells. In particular, long term 
glucose starvation enhances entosis via AMP-activated protein kinase (AMPK) activity 
dependent on changes in cell stiffness (Hamann et al. 2017). Interestingly, mitosis has been 
identified as a trigger for entotic invasion in dividing epithelial adherent cells through mitotic 
rounding mediated by inhibition of Cdc42 in a RhoA-dependent manner (Joanne Durgan et al. 
2017). 
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Entotic invasion requires expression of the tumor suppressor E-cadherin as well as P-cadherin-
associated epithelial adherens junctions between the entotic cells (Sun, Cibas, et al. 2014). As a 
result of epithelial cell-cell contacts, polarized actomyosin contractility is necessary in the 
invading cell to provide the mechanical force allowing cell engulfment, which is regulated by 
Rho-actin signaling and changes in mechanical deformability between the inner and outer cell 
(Overholtzer et al. 2007; Sun, Luo, et al. 2014). Consistent with this, recent studies identified the 
G-protein-coupled LPA receptor 2 (LPAR2) as a promotor of entosis, thus providing evidence that 
extracellular cues can trigger cell-in-cell invasion (Purvanov et al. 2014).  
After cell-in-cell invasion, the most common fate for the invading cell is non-apoptotic cell death 
where the host cell kills and digests the internalized cell through cell cannibalism. This is 
mediated by non-canonical autophagy, lysosomal degradation and nutrient recovery (Figure 13). 
In contrast to phagocytosis, the internalized target cells are viable inside the entotic vacuole for 
an extended period of time. In addition, other cell fates after internalization have been observed 
in which cells occasionally are able to escape from their host cells or divide inside them (Figure 
13) (Overholtzer et al. 2007; Florey et al. 2011). Although the consequences of entosis are not 
well known, some evidence indicates that entosis triggers cancer cell aneuploidy enhancing 
tumor progression. Indeed, after internalization, the host cell sometimes divides, but often fails 
due to aberrant cell division leading to multinucleation, which in turn enhances aneuploidy and 
genomic instability (Figure 13) (Matej Krajcovic et al. 2011; Matej Krajcovic and Overholtzer 
2012; Sun, Luo, et al. 2014). Consistently, the outer cell has been shown to recover nutrients 
from the digested inner cell, promoting cell survival and proliferation (M. Krajcovic et al. 2013). 
A recent study reported that expression of the tumor suppressor CDKN2A inhibits formation of 
cell-in-cell structures (Liang et al. 2018). In contrast, other studies reveal that entosis could act 
as a tumor-suppressive mechanism to clear dysfunctional cells by cell death of the inner cell, for 
instance eliminating aberrant invading cancer cells after internalization (Figure 13) (Sun, Cibas, 
et al. 2014; Florey et al. 2011).  
In conclusion, entosis is a form of non-apoptotic cell death, which can be induced by multiple 
triggers and it is regulated by Rho-actin-signaling and actomyosin contractile forces. However, 
the detailed mechanisms mediating entosis and the impact of transcriptional activity were 
unclear and will be elucidated on this thesis. 
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Figure 13: Consequences of entosis. Cell-in-cell structures most likely end in entotic cell death, whereby 
inner cell death occurs while the outer cell recovers nutrients from the digested internalized cell. 
Alternatively, some entotic cells undergo cell division inside their hosts or escape from the host cells. This 
process has been shown to present anti-tumorigenic effects as a result of killing the internalized tumor 
cell, whereas some evidence supports an oncogenic role, for instance cytokinetic failure in outer cells can 
promote aneuploidy. This image was adapted from (J. Durgan and Florey 2018).  
 
 
 
 
 
 
 
 
 
Introduction 
 
39 
 
1.6. Regulation of the MRTF/SRF transcriptional pathway 
1.6.1. The SRF transcriptional network 
SRF was discovered through the c-fos gene, a homolog oncogene of the FBJ murine 
osteosarcoma gene v-fos (Curran et al. 1982). Early studies with c-fos showed fast RNA synthesis 
upon exposure to growth or differentiation factors (Greenberg and Ziff 1984; Greenberg, 
Greene, and Ziff 1985). A study of the human c-fos gene revealed a cis-element called the Serum 
Response Element (SRE), which was identified to be required for c-fos serum stimulation 
(Treisman 1985) and led to the identification of the Serum Response Factor (SRF) (Treisman 
1986). Analysis of the SRF-DNA interactions showed that SRF binds to its consensus sequence 
CArG-box, a palindromic CC(A/T)6GG sequence (Treisman 1986; Pellegrini, Tan, and Richmond 
1995). This was also demonstrated later by genome-wide analysis (Sullivan et al. 2011; Esnault 
et al. 2014). 
SRF requires the recruitment of co-activators: the Myocardin-related transcriptions factors 
(MRTFs) or the Ternary Complex Factors (TCFs). These two transcriptional cofactors are 
activated by different signaling pathways and control the expression of multiple target genes 
(Figure 14). 
The TCF family is phosphorylated via Erk and activated by MAPK (Mitogen-Activated Protein 
Kinase) (Figure 14) (Gille, Sharrocks, and Shaw 1992; Janknecht et al. 1993). The MAPK signaling 
pathway activates TCFs in the nucleus and forms a complex with SRF at the TCF motif 
(Buchwalter, Gross, and Wasylyk 2004). The discovery of TCFs explained how activation of MAPK 
signaling via mitogens controls SRF regulated genes. Other evidence suggested the involvement 
of another signaling pathway, in which activation of SRF target genes was TCF-independent (C S 
Hill and Treisman 1995) by Rho-mediated signaling (Caroline S Hill, Wynne, and Treisman 1995). 
The discovery of Myocardin, which is involved in cardiac gene expression (D. Wang et al. 2001), 
led to the identification of Myocardin homologues termed Myocardin-related transcription 
factors MRTF-A and MRTF-B (D.-Z. Wang et al. 2002). Myocardin-related transcription factors 
are SRF transcriptional coactivators regulated via the Rho-actin pathway (Figure 14) (Miralles et 
al. 2003). TCFs and MRTFs are independently controlled, although both cofactors allow SRF to 
activate target gene transcription controlling the balance between cell proliferation and 
contractility (Figure 14) (Gualdrini et al. 2016).  
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Figure 14: The SRF transcriptional network: TCF and MRTF. Serum Response Factor (SRF) is activated by 
two different families of transcription factors, the Ternary Complex Factors (TCFs) and the Myocardin-
Related Transcription Factors (MRTFs). The TCF pathway links SRF activity to Ras-Erk signaling, while the 
MRTF pathway associates SRF activity to Rho-actin signaling. Both transcriptional co-activators compete 
for SRF binding and regulate gene expression. TCF-dependent transcription enhances the expression of 
genes involved in cell proliferation, whereas association with MRTFs controls cell contractility and pro-
invasive behaviour (Esnault et al. 2014; Gualdrini et al. 2016). 
1.6.2. The MRTF family of SRF coactivators 
MRTF, also known as megakaryocytic acute leukemia (MAL) and myocardin like protein (MKL-
1), has been shown to be involved in muscle differentiation and cell proliferation (Creemers et 
al. 2006; Wu et al. 2010).  
MRTFs consist of a conserved N-terminal region containing the RPEL motif defined by the amino 
acid sequence Arg-Pro-X-X-X-Glu-Leu, which is essential for G-actin binding (Miralles et al. 2003; 
Guettler et al. 2008). The three RPEL sequences each interact with actin molecules. The linker 
sequences between RPEL1-2 and RPEL2-3 also bind two additional actin molecules with low 
affinity thereby creating a pentavalent G-actin-MRTF complex (Mouilleron et al. 2011). 
Moreover, the MRTF RPEL domain contains two elements called B2 and B3 (Figure 15), which 
are required for nuclear MRTF import allowing the NLS sequence to interact with importin α and 
β (Pawłowski et al. 2010).  
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MRTF further contains a B1 box necessary for ternary complex formation (TCF) and for the 
association of SRF with its target DNA. A hydrophobic region known as Q-box, rich in Q amino 
acids, affects MRTF nuclear localization and is responsible for its interactions with SRF. The MRTF 
C-terminal region contains the conserved SAP domain (SAF-A/B Acinus Pias) providing promoter 
specificity, followed by a leucine-zipper (LZ), which mediates homo- and hetero-dimerization, 
while the transactivation domain (TAD) is essential for SRF activation (Figure 15) (Miralles et al. 
2003; Z. Wang et al. 2003; Zaromytidou, Miralles, and Treisman 2006; E. N. Olson and Nordheim 
2010).  
 
Figure 15: Structure of myocardin-related transcription factors (MRTFs). This figure shows the domain 
organization of the MRTF family, which consists of the myocardin-related transcription factors (MRTF-A 
and MRTF-B) and myocardin (MC). Numbers of amino acids are indicated for each myocardin family 
protein on the right. The RPEL motif contains actin binding sites and the regions B3 and B2, which are 
important for nuclear import, followed by the region B1 involved in ternary complex formation and the 
Glu-rich region Q. An α-helical region between the B1 and Q regions mediates association with SRF. All 
members of the MRTF family present a homologous SAP domain (also called as SAF-A/B, acinus, PIAS) 
required for promoter specificity and the LZ region (leucine zipper) enables MRTF homo- and 
heterodimerization. Finally, the TAD is the transactivation domain which is phosphorylated when MRTF is 
in the nucleus and bound to SRF (Miralles et al. 2003; E. N. Olson and Nordheim 2010).  
1.6.3. Actin-mediated regulation of MRTF 
MRTFs are well characterized actin-binding proteins involved in the regulation of SRF target 
genes (Gineitis and Treisman 2001). MRTF-mediated transcription is dependent on the 
rearrangement of the actin cytoskeleton (Miralles et al. 2003). The subcellular localization of 
MRTF in cells is determined by changes in actin dynamics (Posern, Sotiropoulos, and Treisman 
2002). Stimulation of F-actin polymerization appears to sequester actin from MRTF (Miralles et 
al. 2003; Vartiainen et al. 2007). Thus, G-actin is dissociated from MRTF, thereby exposing the 
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nuclear localization sequence (NLS) at the RPEL domain for subsequent nuclear MRTF import 
(Pawłowski et al. 2010; Miralles et al. 2003). Alternatively, MRTF nuclear export is enhanced 
with the depolymerizing drug Latrunculin B (Lat B), which increases the monomeric G-actin 
concentrations (Vartiainen et al. 2007). Generally, nuclear import of MRTF leads to enhanced 
SRF transcriptional activity (Z. Wang et al. 2004) (Figure 16).  
The MRTF-SRF signaling pathway is regulated by the Rho GTPase-dependent reorganization of 
the actin cytoskeleton. In particular, serum stimulation activates Rho GTPases for formin-
mediated actin polymerization (Copeland and Treisman 2002). As a result, the G-actin 
concentration is reduced in response to Rho signaling, leading to MRTF nuclear accumulation, 
where MRTF binds to SRF and enhances SRF-dependent gene expression (Miralles et al. 2003). 
Previous studies from our group reported the importance of formins in nuclear actin 
polymerization (Baarlink, Wang, and Grosse 2013; Plessner et al. 2015). Importantly, MRTF is 
also regulated by phosphorylation, which in turn contributes to SRF transcriptional activation 
(Panayiotou et al. 2016). In conclusion, regulation of actin-MRTF/SRF transcription is controlled 
by phosphorylation, Rho activation and changes in F-actin/G-actin concentration (Figure 16).  
 
Figure 16: The actin-MRTF/SRF transcriptional feedback. Schematic representation of Rho-actin signaling 
to MRTF/SRF. A pool of cytoplasmic monomeric G-actin binds MRTF preventing MRTF nuclear 
translocation. Upon a stimulus such as serum or LPA, Rho signaling is activated and the total G-actin pool 
is depleted through increased actin polymerization. The change in the G/F-actin ratio releases MRTF, 
which accumulates in the nuclear compartment leading to SRF-dependent transcription of cytoskeletal 
target genes representing a feed-forward loop.  
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1.6.4. MRTF functions 
Previous work has identified 960 serum-inducible SRF target genes, which are mostly controlled 
by MRTF (Esnault et al. 2014). MRTF/SRF-dependent target genes are involved during 
rearrangements of the actin cytoskeleton, thereby controlling cell motility, cell proliferation, cell 
contractility, cell adhesion, extracellular matrix synthesis, muscle differentiation and cell growth 
(Gualdrini et al. 2016; Esnault et al. 2014). Interestingly, a recent study showed that MRTF/SRF 
target genes are also dependent on the Hippo-YAP/TAZ signaling pathway and their crosstalk 
regulates cytoskeletal dynamics (Foster, Gualdrini, and Treisman 2018). 
The SRF transcription factor is a key regulator of cytoskeletal gene expression in many cell types 
and, thus, it is crucial for a variety of physiological and developmental processes such as 
gastrulation, muscle cell function, neuronal development, the immune system and liver 
development and regeneration (E. N. Olson and Nordheim 2010). For instance, SRF is a key factor 
for focal adhesion assembly in mouse embryonic stem cells and deletion of the SRF gene affects 
cell spreading and migration in mouse fibroblasts (Schratt et al. 2002). 
MRTF/SRF and their target genes also play an important role in cell proliferation, invasiveness 
and motility implicated in cancer (E. N. Olson and Nordheim 2010). Studies revealed that MRTF-
A/B are important for motility, adhesion, proliferation, invasiveness and colonization of 
metastatic tumors in melanoma and breast cancer cells (Medjkane et al. 2009). Similarly, 
deletion of MRTF-A affected cell proliferation and the cell cycle in fibroblasts (Shaposhnikov et 
al. 2013). The importance of MRTF for invasive migration was further supported by the 
transcriptional repressor SCAI blocking MRTF in cancer cell invasion (Brandt et al. 2009). 
Moreover, high levels of αV and β1 integrins activate MRTF/SRF activity triggering upregulation 
of ISG15, which enhances breast cancer cell motility (Hermann et al. 2016). Recently, the 
relevance of MRTF for cancer cell metastasis was further demonstrated, as MRTF and YAP are 
activated through L1CAM in disseminated cancer cells for metastatic colonization (Er et al. 
2018). Consistent with this, MRTF-A and YAP are shown to regulate glioblastoma tumorigenicity 
(O. M. Yu et al. 2018). In summary, these findings suggest that MRTF/SRF signaling is 
fundamental for cancer cell invasion controlling a transcriptional-actin cytoskeleton regulatory 
circuit.  
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2. Aim of this study 
Non-apoptotic plasma membrane blebbing is critical for cancer cell motility and subsequent 
tumor dissemination regulated by actin cytoskeleton dynamics (Nürnberg, Kitzing, and Grosse 
2011). A form of bleb-associated invasion characterized by cell-in-cell invasion also termed as 
entosis occurs in human malignancies and can promote tumor progression (Matej Krajcovic et 
al. 2011).  
Previous work reported the importance of polarized actin dynamics mediated by plasma 
membrane blebbing at the invading cell in providing the driving force for entotic invasion 
(Purvanov et al. 2014). Although some of the actin cytoskeleton molecular regulators involved 
during non-apoptotic blebbing are well characterized (Fackler and Grosse 2008), the underlying 
signal transduction pathways for sustained long-term blebbing and consecutive bleb-associated 
cell invasion are not well understood. This invasive phenomenon is a long-term actin-controlled 
process described as a bleb-associated mode of invasive motility. However, whether this actin-
driven blebbing requires transcriptional regulation has not been investigated before. 
One of the prototypic transcriptional pathways known to regulate actin cytoskeleton dynamics 
and enhance the expression of cytoskeletal genes is the MRTF/SRF signaling pathway. MRTF/SRF 
is known to be involved in cell motility and cancer cell invasion. The aim of this thesis was to 
elucidate the potential role of MRTF/SRF transcriptional activity in non-apoptotic plasma 
membrane blebbing for invasive motility during entotic invasion (Figure 17). For that, our first 
objective was to investigate the underlying transcriptional feedback driving long-term plasma 
membrane blebbing. As plasma membrane blebbing occurs during entotic or amoeboid 
invasion, this study will provide insights into the relevance of long-term blebbing for these 
processes. We based our hypothesis on the actin-MRTF/SRF transcriptional pathway and 
assumed a critical function due to high actin remodelling during non-apoptotic blebbing and 
bleb-associated invasion (Figure 17). This study will therefore elucidate the molecular 
mechanisms regulating bleb-associated invasion and provide insights for its physiological 
relevance. 
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Figure 17: Investigating the role of the MRTF/SRF pathway in a bleb-dependent mode of invasion. This 
illustration represents an experimental model to study induced plasma membrane blebbing and 
subsequent entotic invasions. Cells in suspension are seeded on poly-HEMA coated dishes to prevent 
cellular attachment and matrix adhesion. The image was adapted from (Soto Hinojosa et al. 2017). 
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3. Materials and Methods 
3.1. Materials 
Table 1: Reagents used in this work 
Reagent Provider 
Acetic acid Roth 
Acrylamide (30%)- Bisacrylamide (0,8%) 
(Rotiphorese Gel 30) 
Roth 
Actinomycin D Santa Cruz Biotechnology 
Agar Roth 
Agarose NEEO Roth 
Ammonium persulfate (APS) Merck 
Ampicillin Roth 
ATP Sigma-Aldrich 
BES Sigma-Aldrich 
Blebbistatin  Sigma-Aldrich 
(S)-nitro-blebbistatin Cayman Chemical 
Bovine Serum Albumin, Fraction V (BSA) Roth 
Bromophenol Blue Roth 
Buffer Reverse Transcriptase Thermo Scientific 
Calcium Chloride (CaCl2) Roth 
Chloroform Roth 
Cholera toxin Sigma-Aldrich 
Coenzyme A           NanoLight Technology 
Collagen Advanced Biomatrix 
Cycloheximide Sigma-Aldrich 
DAPI Sigma-Aldrich 
Dimethyl Sulfoxide (DMSO) Roth 
DMEM (Dulbecco´s Modified Eagle´s Medium) 
high glucose 
Capricorn 
DMEM/F12 Gibco Life Technologies 
DNA ladder 1kb  Thermo Scientific 
DNA loading dye 6x Thermo Scientific 
dNTPs Promega 
Doxycycline Sigma-Aldrich 
DTT (1,4- dithiothreitol) Roth 
EDTA (Ethylenediaminetetraacetic acid) Roth 
EDTA-Disodium salt dihydrate Roth 
EGTA (ethylene glycol-bis(β-aminoethyl ether)-
N,N,N',N'-tetraacetic acid) 
Roth 
Epidermal growth factor Promo-kinase 
Ethanol Roth 
Ethidium bromide Roth 
Fetal Calf Serum (FCS) Invitrogen 
Fluorescence mounting media DAKO 
Formaldehyde (37%) Roth 
Fugene HD Promega 
Glutamine Capricorn 
Glycerol Roth 
Glycine Roth 
H2O2 Sigma-Aldrich 
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HEPES (Hydroxyethyl piperazine ethanesulfonic 
acid) 
Roth 
Horse Serum Invitrogen 
Hydrochlorothiazide (h-CTZ) NanoLight Technology 
Hydrocortisone Sigma-Aldrich 
Insulin Gibco 
Isopropanol Roth 
Kanamycin Roth 
Lipofectamine LTX Life Technologies 
Lipofectamine RNAiMax Life Technologies 
Luciferin Cayman Chemical 
Magnesium Chloride (MgCl2) Roth 
Matrigel Corning 
MEM Powder GE Healthcare 
2-Mercaptoethanol  Merck 
Methanol Roth 
Milk powder (fat free) Roth 
Nocodazol Cell Signaling 
OptiMEM Invitrogen 
PageRuler Prestained Protein Ladder Thermo Scientific 
Penicillin Capricorn 
Phosphate Buffered-Saline (PBS) Capricorn 
Phusion HF buffer Thermo Scientific 
Phusion Hot Start II DNA Polymerase Thermo Scientific 
Plasmocyn Invitrogen 
Poly-HEMA (poly 2-hydroxyethyl methacrylate)  Polysciences 
Ponceau S solution Sigma-Aldrich 
Potassium chloride Roth 
Primers Sigma-Aldrich 
Protease Inhibitor cocktail Roche 
PTC 124 Selleck Chemicals 
Puromycin Sigma-Aldrich 
Random Hexamer Primer Thermo Scientific 
Restriction enzymes for cloning Thermo Scientific/ New 
England BioLabs (NEB) 
RevertAid Reverse Transcriptase Thermo Scientific 
RiboLock Ribonuclease Inhibitor Thermo Scientific 
RNAase-free water Promega 
si RNA Oligonucleotides QIAGEN 
Sodium chloride (NaCl) Roth 
Sodium dodecyl sulfate (SDS) Roth 
Sodium hydrogen phosphate (Na2HPO4) Roth 
Sodium pyrophosphate (Na4P2O7) Roth 
Streptomycin Capricorn 
SYBR-Green Bio-Rad 
T4 DNA Ligase Thermo Scientific 
TEMED (N, N, N’, N’-Tetramethylethane-1,2-
diamine) 
Roth 
Tris (Tris (hydroxymethyl) aminomethane) Roth 
Triton X-100 Merck 
Trizol Peqlab 
Trypsin-EDTA 0,05% Capricorn 
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Tryptone Roth 
Tween-20 Roth 
Y-27632 Sigma-Aldrich 
Yeast extract Roth 
 
Table 2: Antibodies list 
Antibody Provider 
Alexa Fluor 488 donkey anti-goat IgG Catalog No A11055 Life Technologies 
Alexa Fluor 488 goat anti-mouse IgG Catalog No A11029 Life Technologies 
Alexa Fluor 488 phalloidin Catalog No A12379 Life Technologies 
Alexa Fluor 555 donkey anti-rabbit IgG Catalog No A31572 Life Technologies 
Alexa Fluor 555 phalloidin Catalog No A22287 Life Technologies 
Alexa Fluor 647 phalloidin Catalog No A34055 Life Technologies 
Donkey anti–goat IgG HRP Catalog No.705-035 Jackson Immuno 
Research 
Donkey anti–rabbit IgG Alexa Fluor 488 #R37118 Life Technologies 
Goat anti–mouse IgG Alexa Fluor 555 #A28180 Life Technologies 
Goat anti–MRTF-A C-19 sc-21558 Santa Cruz 
Biotechnology 
Goat anti–rabbit IgG HRP Catalog No. 170-6515 Bio-Rad 
Mouse anti-Ezrin Catalog No. 610602 BD Biosciences 
Mouse anti–GFP B-2 sc-9996 Santa Cruz 
Biotechnology 
Mouse anti-Integrin β1  BD Biosciences 
Mouse anti-mDia1 610849 Catalog No. 610848 BD Biosciences 
Mouse anti–MRTF-A G-8 sc-390324 Santa Cruz 
Biotechnology 
Rabbit anti–MRTF-B #14613 Cell Signaling 
Technology 
Rabbit anti-phospho-
Ezrin(Thr567)/Radixin(Thr564)/Moesin (Thr558) 48G2 
#3726 
Cell Signaling 
Technology 
Rabbit anti-phospho-myosin light chain 2 (Thr18/Ser19) 
#3674 
Cell Signaling 
Technology 
Rabbit anti-Rac-1/2/3 #2465 Cell Signaling 
Technology 
Rabbit anti–SRF G-20 sc-335 Santa Cruz 
Biotechnology 
Rabbit anti-tubulin 11H10 #2125 Cell Signaling 
Technology 
Sheep anti–mouse IgG HRP Catalog No. NA9310 GE Healthcare 
 
Table 3: Biochemical kits used in this work 
Kit Provider 
CellTiter-Fluor Cell Viability Assay Promega 
GenElute Mammalian Total RNA Miniprep 
kit 
Sigma-Aldrich 
Lipofectamine LTX Life Technologies 
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Lipofectamine RNAiMax Life Technologies 
Nextera XT DNA Sample Preparation kit Ilumina 
NucleoBond Xtra Midi Plus Macherey-Nagel 
NucleoSpin gel and PCR clean-up Macherey-Nagel 
NucleoSpin Plasmid Macherey-Nagel 
PureLink HiPure Plasmid Filter Maxiprep 
kit 
Thermo Scientific 
SMART-Seq v4 Ultra Low Input RNA kit  ClonTech 
SuperSignal West Femto Maximum 
Sensitivity ECL Western Blotting Substrate 
Thermo Scientific 
 
Table 4: Buffers and solutions list used in this work 
Solutions Composition 
2x BBS transfection 
buffer 
BES                  
NaCl                 
Na2HPO4              
 
50 mM 
280 mM 
1.5 mM 
pH 6.92 
8% Formaldehyde Formaldehyde in PBS 8% (v/v)  
4% Formaldehyde Formaldehyde in PBS 4% (v/v)  
ECL solution 2 
(Enhanced 
Chemiluminescence) 
Tris-HCl 
H2O2 
0.1 M 
1.8% 
pH 8.5 
ECL solution 1 
(Enhanced 
Chemiluminescence) 
Tris-HCl 
Luminol 
p-Coumaric acid 
0.1 M 
2.5 mM 
0.4 mM 
pH 8.5 
Firefly assay buffer  
3X 
DTT      
Coenzyme A 
ATP 
Luciferin 
In Triton-lysis-buffer without 
Triton 
15 mM 
0.06 mM 
0.45 mM 
4.2 mg/ml 
Laemmli buffer 4X Tris-HCl              
EDTA                
Glycerol              
SDS                  
Bromophenol blue    
2-Mercaptoethanol    
286 mM 
10 mM 
28 % (v/v) 
5.7 % (w/v) 
3.5 mg/ml 
4.7 mg/ml 
pH 6.8 
LB agar NaCl  
Yeast extract    
Tryptone   
Agar 
1% (w/v) 
0.5 % (w/v) 
1 % (w/v) 
1.5 % (w/v) 
LB medium NaCl                       
Yeast extract 
Tryptone
  
1 % (w/v) 
0.5 % (w/v) 
1% (w/v) 
Loading buffer for PCR 
6X 
Glycerol  
Bromophenol blue  
Orange G 
40 % (v/v) 
0.04 % (w/v) 
0.2 % 
PBS Na2HPO4                   8 mM    pH 7.4 
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KH2PO4                    
NaCl                  
KCl                    
1.5 mM 
140 mM 
2.7 mM 
PBS-T PBS 
Triton X-100            
1x 
0.3 % (v/v) 
Renilla assay buffer 3X 10 mM PTC124 in DMSO        
2 mM h-CTZ in ethanol         
in Renilla solution 
0.06 mM 
0.01 mM 
 
Renilla solution 
10X 
Na2EDTA               
Na Pyrophosphate      
NaCl                   
in H2O 
45 mM 
30 mM 
1.452 M 
SDS-PAGE  
running buffer 1x 
Tris-HCl                
Glycine                
SDS                    
25 mM 
192 mM 
0.1 % (w/v) 
pH 8.3 
SDS-PAGE  
stacking gel 
30% Acrylamide/       
0.8% Bisacrylamide   
4X buffer Tris/SDS       
Tris-HCl                 
SDS                    
TEMED                 
10% APS                
in H2O                  
1 ml (v/v) 
 
1.25 ml           pH 6.8 
0.5 M 
0.2 % (w/v) 
10 l 
25 l (w/v) 
3 ml 
SDS-PAGE  
separating gel 
30% Acrylamide/        
0.8% Bisacrylamide   
4X buffer Tris/SDS        
Tris-HCl                 
SDS                     
TEMED                  
10% APS                
in H2O 
6-15 % (v/v) 
 
1.25 ml          pH 8.8 
3 M 
0.2 % (w/v) 
20 l 
100 l (w/v) 
TBST buffer NaCl                    
Tris-HCl                 
Tween-20               
500 mM 
20 mM 
1 % (v/v) 
pH 7.5 
Tris-Acetat (TAE) buffer Tris                     
EDTA                  
Acetic acid              
40 mM           pH 8.0 
2 mM 
20 mM 
 
Triton lysis buffer 
10X 
Tris-HCl                  
Tris-Base powder         
5 M NaCl                     
1 M MgCl2                    
Triton-X-100              
in H2O 
0.1082 M 
0.0419 M 
75 mM 
3 mM 
0.25 % (v/v) 
Western blot  
blocking buffer 
Milk powder          
in TBS-T buffer 
5% (w/v) 
Western blot  
transfer buffer 
Tris                      
Glycine                  
Methanol                
SDS                  
25 mM             pH 8.5 
192 mM 
10 % (v/v) 
0.2 % (w/v) 
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Table 5: Lab equipment and material list 
Device Provider 
40x oil objective  Carl Zeiss 
63x 1.4 NA oil objective  Carl Zeiss 
Centrifuge 5415R Eppendorf 
Centrifuge Biofuge Pico Heraeus 
Centrifuge Biofuge Stratos Heraeus 
CO2 humidified incubation chamber Pecon 
Forma Series II 3110 Water-Jacketed CO2 
Incubators 
Thermo Scientific 
GenAmp PCR system 9700 Applied Biosystems 
INFINITY Gel Documentation Peqlab 
Laser scanning confocal microscope LSM 
700 
Carl Zeiss 
Laser scanning confocal microscope LSM 
800 
Carl Zeiss 
Luminoskan Ascent Microplate 
Luminometer 
Thermo Scientific 
Medical X-ray Film Kodak Film 
Mini-PROTEN Tetra Cell System  Bio-Rad 
Mini-Trans Blot Electrophoretic Cell System Bio-Rad 
NanoDrop 1000  Peqlab 
Nikon Eclipse microscope Nikon 
Nitrocellulose blotting membrane GE Healthcare 
PCR Thermocycler T3 Biometra 
pH-meter 70 Mettler Toledo 
qPCR 96-wells plate Sarstedt 
Real time Quantitative Thermal Cycler iQ5 
(qPCR) 96 well  
Bio-Rad 
Thermomixer compact Eppendorf 
Vortex Genie 2 Scientific Industries 
xCELLigence system Real-Time Cell Analyzer 
RTCA-MP 
Roche Diagnostics 
X-ray film processor Medical Index 
 
Table 6: Software list 
Software Provider 
Ascent software Thermo Scientific 
DNA Strider Christian Marck 
Illustrator CS6 Adobe 
Image J /Fiji National Institute of Health 
MS Office 2015 Microsoft 
Photoshop CS6 Adobe 
Prism 6 Graph Pad Software 
RTCA Software 1.2 Roche Diagnostics 
ZEN software Carl Zeiss 
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3.2. Cell culture methods 
3.2.1. General cell culture 
Human MCF10A cells were cultured in DMEM/F12 (Gibco Life Technologies) supplemented with 
5% horse serum, 20 ng/ml epidermal growth factor, 10 g/ml insulin, 0.5 g/ml hydrocortisone, 
100 ng/ml cholera toxin, 100 U/ml penicillin, and 100 g/ml streptomycin at 37 °C in a 5% CO2 
atmosphere as described by (Debnath, Muthuswamy, and Brugge 2003). 
Human HEK293T, HeLa and A375-M2 were maintained in DMEM HPSTA-high glucose, stable 
glutamine and sodium pyruvate (Capricorn) supplemented with 10% FCS, 2 mM glutamine, 100 
U/ml penicillin, and 100 g/ml streptomycin at 37 °C in a 5% CO2 atmosphere. 
Culturing of all cell lines was performed in a cell culture laminar-flow hood under sterile 
conditions. All solutions were stored at +4 °C and warmed up to 37 °C in a water-bath before 
use. In order to split cells, the medium was completely aspirated and the cells were washed with 
PBS. Then, cells were incubated with Trypsin at 37 °C until cells were detached. Finally, Trypsin 
was inactivated by adding cell medium. 
Freezing Cultured Human Cell Lines  
To freeze cells for long term storage, cells were trypsinized and mixed with cell medium to 
harvest them. Subsequently, cells were centrifuged at 3000 rpm for 5 minutes. Afterwards, the 
medium was aspirated and cells were resuspended in 1 ml of cell culture freezing medium 
containing 5 % DMSO and 20% FCS. The resuspended cell solution was transferred to Cryo-tubes 
and placed at -80 °C in an isopropanol-containing cell freezing container to guarantee a slow 
freezing process. After 24 hours, the tube was placed at -80 °C or in liquid nitrogen for long term 
storage. 
Thawing Human Cell Lines 
The cell line aliquots were stored in 1 ml freezing medium at -80 °C or in liquid nitrogen. To grow 
a cell line, the frozen sample was thawed in a 37 °C water bath for 5 minutes. Afterwards, 
samples were transferred into a 15 ml tube and mixed with 10 ml of medium. The suspended 
cells were centrifuged at 3000 rpm for 5 minutes to isolate the cell pellet free of DMSO from the 
freezing medium. After removing the supernatant, the pellet was resuspended in 10 ml of the 
cell line´s medium and, finally cells were stored in a 5% CO2 atmosphere at 37 °C. 
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Table 7: Cell lines 
Cell line Species Media Origin 
MCF10A Homo Sapiens DMEM/F12 Epithelial mammary gland  
(Tait, Soule, and Russo2 1990) 
HEK 293 T Homo Sapiens DMEM Epithelial embryonic kidney (Graham et 
al. 1977) 
A375-M2 Homo Sapiens DMEM Malignant melanoma, provided by E. 
Sahai (The Francis Crick Institute, London) 
HeLa Homo Sapiens DMEM Epithelial cervix adenocarcinoma 
(SCHERER, SYVERTON, and GEY 1953)  
 
3.2.2. DNA transfection 
a. Calcium Phosphate Precipitation Method 
HEK293T cells were transfected using the calcium phosphate method. Cells were seeded 24 
hours before transfection. For a 3.5 cm culture dish, 1g of DNA was diluted and mixed with 
112.5 l of H2O. Subsequently, 125 l 2xBBS was added, followed by 12.5 l CaCl2. After 
vortexing, the transfection mixture was incubated for 15 minutes at room temperature before 
adding it to the cells. After four hours transfection, the cell medium was replaced with fresh 10% 
FCS DMEM medium and cells were incubated overnight (o/n) at 37 °C in a 5% CO2 atmosphere.  
b. Fugene Transfection Method 
Cells were transfected using Fugene (Promega) according to the manufacturer´s instructions. 
The DNA was mixed in 200 l OptiMEM (Invitrogen), followed by 4 l of Fugene for each g DNA. 
After 15 minutes of incubation at room temperature, the transfection mixture was added to the 
cells which were plated in a 3.5 cm culture dish the day before. Cells were incubated overnight 
at 37 °C with 5% CO2.  
c. Lipofectamine Transfection LTX 
Cells were transfected using Lipofectamine LTX and Plus Reagent kit (Invitrogen) according to 
the manufacturer´s instructions. Cells were seeded the day before transfection in a 3.5 cm 
culture dish to be 70% confluent for transfection. To transfect the plasmids, 1g of DNA was 
diluted in 200 l of OptiMEM Medium (Invitrogen), followed by 7-10 l Lipofectamine LTX 
Reagent and then 5 l of Plus Reagent was added to the solution. Upon mixing and vortexing, 
the solution was incubated for 10 minutes at room temperature. Subsequently, the transfection 
mixture was added to the cells and they were incubated overnight at 37 °C with 5% CO2. 
3.2.3. siRNA transfection 
MCF10A, HeLa and A375-M2 cells were transiently transfected with 30 nM of siRNA 
oligonucleotides using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer´s 
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instructions. For gene silencing, cells were seeded the day before transfection in a 3.5 cm culture 
dish to be 50-60% confluent during transfection. Then, 5 l of Lipofectamine RNAiMAX Reagent 
was diluted and mixed in 125 l OptiMEM Medium. Simultaneously, 3.1 l siRNA of a 20 M 
siRNA solution were diluted with 125 l OptiMEM Medium. Both solutions were mixed together 
and incubated for 10-15 minutes at room temperature. Afterwards, the transfection mixture 
was added to the cells and incubated for 72h at 37 °C with 5% CO2. After 72 hours, knockdown 
efficiency was quantified and confirmed by Western blot analysis or by quantitative PCR. 
All siRNAs were purchased from Qiagen. The targeting sequences of siRNAs used in this work 
are indicated in Table 8. 
Table 8: siRNA sequences 
siRNA name Gene Target sequence (5′ -> 3′) 
Hs_SRF_5 SRF 5′-CAAGATGGAGTTCATCGACAA-3′ 
Hs_VIL2_1 Ezrin 5′-ACTAAGCTCTTATTAGCGCTC-3 
Hs_MKL1_7 MRTF-A 5′-ATCACGTGTGATTGACATGTA-3′ 
Hs_MKL1_9 MRTF-A 5′-TACCTCTATATTATATATCGA-3′ 
Hs_MKL2 MRTF-B 5′-AAGTAACAGTGGGAATTCAGC-3′ 
Hs_DIAPH1_1 mDia1 5′-AAGATATGAGAGTGCAACT-3′ 
All stars negative control 
siRNA 
control siRNA 5′-AATTCTCCGAACGTGTCACGT-3′ 
  
3.2.4. Generation of stable cell lines by virus transduction 
3.2.4.1. Lentiviral plasmids transfection 
The advantage of stable transduction over transient transfection is the incorporation of the 
genetic material into the genome of the transduced cell. For that, HEK293T cells were seeded in 
a 6-well plate the day before transfection until reaching 70% confluence. To produce the 
lentivirus, HEK293T cells were co-transfected using the calcium phosphate method with the 
lentiviral packaging vector psPAX, the envelope vector pMDG.2 and a lentiviral vector such as 
the pInducer20 (pIND20), pWXPL or FUGW cloned with the targeted DNA of choice. The 
pInducer20 system presents doxycycline-inducible expression (Meerbrey et al. 2011) while the 
pWXPL and FUGW lentiviral systems show constitutive expression. In order to co-transfect cells, 
the total amount of DNA (2 g pMDG.2, 2 g psPAX and 1 g of the targeted lentiviral vector of 
interest) was diluted in 112.5 l of H2O. Then, 125 l 2xBBS were added to the transfection 
mixture, followed by 12.5 l of CaCl2. After mixing and vortexing, the transfection mixture was 
incubated for 15 minutes at room temperature and afterwards added to the cells. After four 
hours transfection, the cell medium was replaced with fresh 10% FCS DMEM medium and cells 
were incubated at 37 °C with 5% CO2. 
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The lentiviral packaging vector psPAX, the envelope lentiviral vector pMDG.2 and the lentiviral 
pWPXL were provided by J. Swiercz (Max Planck Institute for Heart and Lung Research, Bad 
Nauheim, Germany). The lentiviral vector FUGW was kindly provided by D. Oliver (University of 
Marburg). Table 9 shows the lentiviral plasmids used on this study to generate stable cells lines. 
Table 9: Lentiviral expression vectors used to generate stable cell lines 
Donor organism Receiver 
organism 
Lentiviral Vector DNA transferred 
Aequorea Victoria and 
Homo Sapiens 
MCF10A 3RPEL-2GFP-pWPXL 3RPEL-2GFP 
Aequorea Victoria and 
S. Cerevisiae 
MCF10A LifeAct-GFP-pWPXL LifeAct-GFP 
Homo Sapiens and 
Aequorea Victoria 
MCF10A  Ezrin-GFP-pWPXL Ezrin-GFP 
Homo Sapiens and 
Aequorea victoria 
MCF10A Ezrin-T567A-GFP-
pWPXL 
Ezrin-T567A-GFP 
Discosoma sp, S. Cerevisiae 
and Homo sapiens 
MCF10A Ezrin-mCherry-
pWPXL 
Ezrin-mCherry 
Aequorea Victoria MCF10A pWPXL GFP 
Aequorea Victoria and 
Homo Sapiens 
MCF10A MRTF-A-GFP-
pInducer20 
MRTF-A-GFP 
Aequorea Victoria, Homo 
Sapiens and Discosoma sp 
MCF10A H2B-mCherry-
pWPXL + 
Ezrin-GFP-pWPXL 
H2B-mCherry 
Ezrin-GFP 
Discosoma sp and S. 
Cerevisiae 
MCF10A LifeAct-mCherry-
pWPXL 
LifeAct-mCherry 
Aequorea Victoria and 
Homo Sapiens 
MCF10A N-MRTF-A-GFP-
pInducer20 
N-MRTF-A-GFP 
Aequorea Victoria, Homo 
Sapiens and Discosoma sp 
MCF10A H2B-GFP-pWPXL + 
LifeAct-mCherry- 
pWPXL 
H2B-GFP 
LifeAct-mCherry 
Aequorea Victoria and 
Homo Sapiens 
MCF10A 3Da.luc-MRTF-SRF-
GFP-FUGW 
3Da.luc-MRTF-SRF-
GFP 
Aequorea Victoria and 
Homo Sapiens 
MCF10A 3Da.luc -GFP-FUGW 3Da.luc -GFP 
Aequorea Victoria and 
Homo Sapiens 
MCF10A GFP-FUGW GFP 
Aequorea Victoria A375-M2 pWPXL GFP 
Aequorea Victoria A375-M2 LifeAct-GFP-pWPXL LifeAct-GFP 
Aequorea Victoria, Homo 
Sapiens and Discosoma sp 
A375-M2 H2B-mCherry-
pWPXL + LifeAct-
GFP-pWPXL 
H2B-mCherry + 
LifeAct-GFP 
Aequorea Victoria and 
Homo Sapiens 
A375-M2 MRTF-A-GFP-
pInducer20 
MRTF-A-GFP 
Aequorea Victoria, Homo 
Sapiens and Discosoma sp 
MCF10A H2B-mCherry-
pWPXL + MRTF-A-
GFP-pIND.20 
H2B-mCherry 
MRTF-A-GFP 
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3.2.4.2. Viral transduction 
HEK293T transfection efficiency was confirmed using fluorescence microscopy after 24 hours of 
transfection. Then, 48 hours after co-transfection of the lentiviral vectors, the supernatants 
containing viral particles were harvested, filtered with a 0.22 m pore size filter and added to 
the target cell line to transduce them. After 72 hours, target cells transduction efficiency was 
confirmed using fluorescence microscopy. Consequently, transduced target cells were selected 
either by FACS-based cell sorting for the pWXPL or FUGW lentiviral plasmids system or by 0.25 
µg/ml puromycin selection for the pInducer20 lentiviral system. In addition, expression of MRTF-
A-GFP from pInducer20 was induced by 333 ng/ml doxycycline.  
3.2.5. Cell impedance analysis 
Cell impedance quantification in A375-M2 melanoma cells was performed in 96-well E-plates 
(Roche Diagnostics), which were previously coated with the indicated collagen concentration 
and cells were seeded on top at the indicated cell densities. Next, impedance-based real time 
detection was conducted using the xCELLigence system Real-Time Cell Analyzer RTCA-MP 
(Roche Diagnostics). Analysis was performed recording the cell index values (CI) every 15 min 
for 24 h and normalization was done using the RTCA Software 1.2 (Roche Diagnostics). The 
impedance readout shows arbitrary cell index-values which are normalized to 1 at the indicated 
time points. The normalized values are calculated using the following equation: Normalization 
of cell index (𝑁𝐶𝑙𝑡𝑖) =  𝐶𝑙𝑡𝑖/𝐶𝑙𝑛𝑚𝑙_𝑡𝑖𝑚𝑒, where Clti is the cell index at a given time point 
divided by the cell index at the normalization time point (Clnml_time). Furthermore, background 
impedance caused by the collagen and the cell medium was determined in each well before 
seeding the cells. Here, cell impedance measurement allows us to monitor different cell 
processes such as cell adhesion (Rees and Thomas 2015). 
3.3. DNA cloning methods 
3.3.1. Amplification of DNA via Polymerase Chain Reaction (PCR) 
Expression constructs were generated following standard cloning methods. DNA fragments 
were amplified by Polymerase Chain Reactions (PCR) using 0.5 l Hot Start II High-Fidelity DNA 
Polymerase in 10 l 5x Phusion buffer (Thermo Fisher Scientific) according to the manufacturer´s 
instructions. Moreover, the PCR reaction contained 200 ng DNA template, 100 nM of forward 
and reverse primer, and optionally 0.5-1.5 l DMSO. Then, the PCR tube was filled up to a total 
volume of 50 l with ddH2O. The PCR reaction was performed using a Thermocycle (Biometra) 
with the program described in Table 10. 
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Table 10: PCR program 
The DNA template was always obtained from existing plasmids. The different pre-existing 
plasmids and expression vectors used on this study are listed and described in Table 11. 
Table 11: Expression plasmids used in this work 
Plasmid Reference Characteristics 
pGL3D.AFOS R. Treisman (The 
Francis Crick Institute, 
London, UK) 
 
(Mohun, Garrett, and 
Treisman 1987) 
 
 
pGL3-basic vector with 3-main SRF 
binding sites of the c-Fos promoter, 
retrieved from the TATA box of a 
Xenopus laevis actin genome. It 
mediates SRF-dependent expression 
of firefly-luciferase. 
pRL-TK Promega Internal control for reporter gene 
assays. Herpes simplex Thymidine 
kinase promotor mediates Renilla 
reniformis luciferase-expression.  
pInducer20  Mammalian expression. Lentiviral 
plasmid. Ampicillin resistance. CMV 
promoter. 
pWPXL  Mammalian expression. Lentiviral 
plasmid. Ampicillin resistance. EF-1α 
promoter. 
pMD2.G J. Swiercz (Max Planck 
Institute for Heart and 
Lung Research, Bad 
Nauheim, Germany) 
Mammalian expression. Lentiviral 
envelope expressing plasmid. 
Ampicillin resistance. 
psPAX2 J. Swiercz (Max Planck 
Institute for Heart and 
Lung Research, Bad 
Nauheim, Germany) 
Mammalian expression. Lentiviral 
packaging plasmid. Ampicillin 
resistance.  
H2B-mCherry-pWPXL  Nuclear marker histone fusion 
protein H2B in a lentiviral vector. 
LifeAct-mCherry-pWPXL M. Sixt (IST, 
Klosterneuburg, 
Vienna) 
LifeAct probe expressed in a lentiviral 
vector. 
N-MRTF-A-GFP-
pInducer20 
Cloned by C. Baarlink 
(Institute of 
Pharmacology, 
Marburg) 
This constitutively active N-MRTF-A 
construct (Miralles et al. 2003) 
cannot bind G-actin due to a lack of 
RPEL motifs. This vector was labelled 
with GFP and inserted in an inducible 
lentiviral vector. 
 Steps Temperature (°C) Time (sec) 
1 initial denaturation 95°C 3 min 
2 denaturation 95 °C 30 sec      Steps 2-4 (30 cycles) 
3 primer annealing 60°-72 °C 30 sec 
4 elongation 72 °C 30 sec/ 1kb   
5 final extension 72° 3 min 
6 storage +4°C  
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MRTF-A-GFP-pInducer20 Cloned by D. Brandt 
(Institute of 
Pharmacology, 
Marburg) 
Full length MRTF-A expressed in an 
inducible lentiviral vector. 
3-RPEL-2-GFP-pWPXL Cloned as explained at 
Table 12. 
RPEL domain from the MRTF-A 
sequence constitutively expressed in 
a lentiviral vector.  
Ezrin-GFP-pWPXL Cloned as explained at 
Table 12. 
(Crepaldi et al. 1997) 
Ezrin wild type form tagged to GFP 
constitutively expressed in a 
lentiviral vector. 
Ezrin-T567A-GFP-pWPXL Cloned as explained at 
Table 12. 
(Gautreau, Louvard and 
Arpin, 2000)  
Ezrin non-phosphorylatable mutant 
T567A tagged to GFP constitutively 
expressed in a lentiviral vector. 
Ezrin-mCherry-pWPXL Cloned as explained at 
Table 12. 
Ezrin wild type form tagged to 
mCherry constitutively expressed in 
a lentiviral vector. 
3Dafos.Luc-T2A-GFP-
FUGW 
Cloned as explained at 
Table 12. 
Lentiviral luciferase promoter SRF 
reporter gene expressing vector. 
hUbC-Luc-T2A-GFP-
FUGW 
Cloned as explained at 
Table 12. 
Lentiviral luciferase reporter gene 
vector with the hUbC promoter 
instead of the SRF firefly promoter. 
Luc-T2A-GFP-FUGW Cloned as explained at 
Table 12. 
Lentiviral luciferase reporter gene 
expressing vector with no promoter. 
 
Lentiviral expression vectors pWPXL-based for stable expression of fluorescently tagged 3RPEL-
2GFP, Ezrin-GFP, Ezrin-T567A-GFP, Ezrin-mCherry, H2B-GFP, H2B-mCherry, LifeAct-mCherry, 
LifeAct-GFP and the pInducer20-based doxycycline inducible vector (Meerbrey et al. 2011) for 
MRTF-A-GFP and N-MRTF-A-GFP were cloned using standard PCR techniques.  
Lentiviral luciferase reporter gene vectors FUGW-based expressing the firefly luciferase 
promoter pGL3D.AFOS to measure SRF luciferase activity were cloned to generate a stable cell 
line. The firefly coding sequence pGL3D.AFOS (Geneste, Copeland, and Treisman 2002) was 
cloned into the lentiviral vector FUGW by inserting either the GL3D.AFOS promoter, the hUBc 
promoter or by removing both promoters as a negative control vector, respectively (Figure 18). 
The SRF luciferase promoter was cloned into the lentiviral vector FUGW maintaining the hUBC 
promoter as hUBc-driven construct or cloned with no promoter deleting the luciferase promoter 
and the hUBc promoter as a promoter free construct. For all luciferase reporter gene expressing 
cloned vectors, the luciferase reporter gene was cloned linked to a GFP by a self-cleavable T2A 
peptide in order to FACS sort the positive transduced cells. The pGL3D.AFOS vector presents the 
cFos promoter and three copies of the serum response element (SRE), serving for the SRF-
dependent expression of the firefly luciferase. 
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Figure 18: The SRF luciferase reporter constructs. The promoter-free construct was generated by 
omitting either the insertion of a GL3D.AFOS promoter or a hUbC promoter into the FUGW lentiviral 
vector serving as non-inducible control plasmid for the SRF luciferase reporter assays. The hUbC-driven 
construct was cloned into FUGW conserving its own hUbC promoter. The CArG-(MRTF/SRF)-driven 
construct was cloned inserting the GL3D.AFOS promoter into the lentiviral FUGW vector. All constructs 
were cloned linked to a GFP sequence. This image was adapted from (Soto Hinojosa et al. 2017). 
The following primer oligonucleotides were used for the generation of the mentioned 
constructed above (Table 12): 
Table 12: Primers sequences for the generation of recombinant DNA 
Construct Sequence (5′ -> 3′) Backbone vector 
Restrictions sites 
Ezrin-GFP  pWPXL 
fwd primer GCGCGCGTTTAAACTAATGCCGAAACCAATCAATGTCC
GA 
PmeI 
rev primer GCGCGCACGCGTCTTGTACAGCTCGTCCATGCCGAGA
GTG 
MluI 
Ezrin-T567A-
GFP 
 pWPXL 
fwd primer GCGCGCGTTTAAACTAATGCCGAAACCAATCAATGTCC
GA 
PmeI 
rev primer GCGCGCTTCGAACTTGTACAGCTCGTCCATGCCGAGA
GTG 
BstBI 
Ezrin-mCherry  H2B-mCherry-pWPXL 
fwd primer GCGCGCGTTTAAACTAATGCCGAAACCAATCAATGTCC
GA 
PmeI 
rev primer GCGCGCACGCGTCTTGTACAGCTCGTCCATGCCGAGA
GTG 
MluI 
3-RPEL-2-GFP  pWPXL 
fwd primer GCGCGCGTTAAACATGCTGCCCCCTTCCGTCATTGCTGTG
AATGG 
PmeI 
rev primer GCGCGCACGCGTCTTGTACAGCTCGTCCATGCCGAGAGT
G 
MluI 
3Dafos.Luc-
T2A-GFP 
 FUGW 
fwd primer GCGCGCTTAATTAACATTTCACACAGGAAACAGCTATG
AC 
PacI 
rev primer GCGCGCGAATTCTTACTTGTACAGCTCGTCCATGCCGA EcoRI 
hUbC-Luc-T2A-
GFP 
 FUGW 
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fwd primer GCGCGCGGATCCCATGGAAGACGCCAAAAACATAAAG
AA 
BamHI 
rev primer GCGCGCGAATTCTTACTTGTACAGCTCGTCCATGCCGA EcoRI 
Luc-T2A-GFP  FUGW 
fwd primer GCGCGCTTAATTAAATGGAAGACGCCAAAAACATAAA
GAA 
PacI 
rev primer GCGCGCGAATTCTTACTTGTACAGCTCGTCCATGCCGA EcoRI 
 
3.3.2. Agarose gel electrophoresis and purification of the PCR products 
The PCR products were mixed with DNA loading dye, the 6x PCR sample loading buffer (Thermo 
Scientific), and subsequently loaded to 1% agarose gel which contained 1x TAE buffer with 10 
µg/µl ethidium bromide. The DNA fragments were separated by running the gel in a DNA 
electrophoresis chamber (Bio-Rad) using a constant voltage (100 V). Later, the amplified DNA 
was detected under UV light and visualized with the INFINITY gel documentation system 
(Peqlab). The amplified DNA fragments of interest were then cut out of the agarose gel and 
purified using the NucleoSpin gel and PCR clean-up kit (Macherey-Nagel) according to the 
manufacturer´s instructions.  
3.3.3. Restriction digest and DNA ligation 
After PCR product purification, the purified PCR fragments and the respective cloning vectors 
were digested using DNA restriction enzymes for 2 hours at 37 °C in accordance with the 
manufacturer´s protocol. The different restriction endonucleases used on this study are shown 
in Table 13. All the restriction enzymes were purchased either from Thermo Scientific or New 
England Biolabs (NEB) as indicated. After digestion, the DNA insert and the digested vector were 
run on an agarose gel and the DNA was purified as previously described. Thereafter, DNA ligation 
was conducted in a total volume of 20 µl for 20 minutes at room temperature using 1 µl of T4 
Ligase (Thermo Scientific) together with 2 µl Ligase buffer (Thermo Scientific) at a ratio of 1:4 
between the digested vector and the DNA insert, respectively. 
Table 13: Restriction enzymes used for this study 
Restriction 
endonucleases 
Reaction Buffer Supplier 
BstBI  
Buffer B 
 
 
Thermo Scientific 
 PmeI 
PmeI  
CutSmart buffer 
 
NEB 
MluI 
PacI  
CutSmart buffer 
 
NEB 
EcoRI 
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BamHI  
Tango buffer 
 
Thermo Scientific 
EcoRI 
 
3.3.4. Transformation of recombinant vector DNA into bacteria  
DH5α bacteria cells were transformed with recombinant DNA by adding 6 µl of the ligation 
reaction to 45 µl bacterial cells on ice for 30 minutes. Then, a 45 seconds heat shock at 42 °C 
was applied and the cells kept on ice for 5 minutes. Next, the samples were plated on LB agar 
plates with antibiotic (either ampicillin or kanamycin depending on the vector resistance) and 
incubated at 37 °C overnight.  
The following day, bacterial colonies were collected and incubated in 4 ml LB medium containing 
antibiotics at 37 °C overnight. DNA plasmids were isolated using the NucleoSpin Plasmid 
Miniprep Kit (Macherey-Nagel) according to the manufacturer´s protocol. Positive clones were 
selected after running a test digestion for all the clones. In order to confirm our cloned construct, 
the isolated DNA plasmids were sent for DNA sequencing (Macrogen) and analyzed with the 
DNA Strider software. 
3.4. Microscopy 
Microscopic imaging was performed using the confocal laser scanning microscopes LSM 700 and 
LSM 800 (Carl Zeiss) equipped with a 63x 1.4 NA and a 40x oil objective (Carl Zeiss). The images 
were later on analyzed using ZEN software (Carl Zeiss) and processed using Image J/Fiji software 
(National Institute of Health).  
3.4.1. Immunofluorescence 
Cells were seeded and grown on glass coverslips (Thermo Scientific) in 6-well plates (Sarstedt). 
For immunofluorescence, cells were fixed with 4% formaldehyde in PBS for 10 minutes at room 
temperature. After washing the coverslips three times with PBS, cells were permeabilized using 
0.03% Triton-X-100 in PBS (PBS-T) or 0.05% Tween in PBS for 10 minutes at room temperature. 
Then, cells were blocked using 5% BSA in PBS for 1 hour at room temperature. Subsequently, 
samples were incubated with the primary antibody diluted in the blocking solution overnight at 
4 °C followed by three PBS washing steps. The secondary antibody was also diluted in the 
blocking solution and incubated with the coverslips for 1 hour at room temperature. If required, 
nuclei were stained using DAPI (Sigma-Aldrich) at 1:10000 for 20 min at room temperature and 
F-actin was labelled using Alexa Fluor 555-phallodin, Alexa Fluor 488-phalloidin or Alexa Fluor 
647-phalloidin (Invitrogen) at 1: 500 overnight at 4 °C or at 1:200 for 1h at room temperature. 
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After three final washing steps with PBS, the coverslips were mounted on the glass slides using 
fluorescent mounting media (DAKO). 
3.4.2. Live Cell Imaging 
Time-lapse microscopy of the fluorescence GFP or mCherry tagged proteins was performed at 
37 °C in a 5% CO2-humidified incubation chamber (Pecon, CO2 module S1). Images were acquired 
with the LSM 700 and the LSM 800 confocal microscopes (Carl Zeiss) using the time series, Z-
stack and tile scan setting of the ZEN software (Carl Zeiss). Quantitative analysis of the images 
was done using the ZEN software (Carl Zeiss) and ImageJ/Fiji software (National Institute of 
Health).  
To induce plasma membrane (PM) blebbing and subsequent entosis, MCF10A cells were seeded 
on 35-mm glass bottom dishes (In vitro Scientific) which were previously coated at room 
temperature with 12% poly-HEMA wt/wt solution diluted 1/4 in ethanol to prevent cellular 
attachment as previously described by (Overholtzer et al. 2007). Whereas to study amoeboid 
blebbing invasion, 8-well µ-slide (Ibidi) were coated with either 2.4 µg/ml Collagen (Advanced 
Biomatrix) or 2.5 µg/ml Matrigel (Corning) according to the manufacturer´s instructions, and 
A375-M2 cells were seeded in DMEM medium on top of the matrix to monitor them over a time 
course of 16 hours.  
To perform live serum stimulation assays, MCF10A cells were starved overnight in a 0.5% FCS 
containing cell medium and 20% serum was added directly to the cells under the microscope to 
follow the effects of the stimulation over time.  
When indicated, cells were treated with the following drugs: the myosin II inhibitor (S)-nitro-
blebbistatin (100 µM, Cayman Chemical), the ROCK inhibitor Y-27632 (10 µM, Sigma-Aldrich), 
the transcription inhibitor Actinomycin D (50 µg/ml, Santa Cruz Biotechnology) and the protein 
translation inhibitor Cycloheximide (100 µg/ml, Sigma-Aldrich), which were applied directly to 
the cells while scanning. 
If necessary, cells were pre-seeded on glass bottom dishes (In vitro Scientific) and transfected 
with the DNA plasmids of interest using Lipofectamine LTX Transfection Kit (Life Technologies) 
24 hours before analysis. To image cells silenced by siRNAs, transfection using Lipofectamine 
RNAiMax Transfection Kit (Life Technologies) was done 72 hours before imaging.  
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3.5. Bleb-dependent invasion assays 
3.5.1. Entosis assays 
Entosis experiments were performed as previously described (Purvanov et al. 2014; Soto 
Hinojosa et al. 2017). MCF10A cells were grown in a 6-well plate and trypsinized to plate them 
at cell densities of 300.000-400.000 per well on Costar Ultra-low cluster plates (Corning) 
preventing cellular attachment. Cells were incubated for 4h at 37°C, then MCF10A cells were 
fixed directly in suspension using 8% formaldehyde in PBS for 10 minutes at room temperature. 
After washing the cells, the cell pellet was resuspended in PBS and seeded on top of 12-mm 
coverslips (Sarstedt) on a heating block at 60 °C for 5-10 minutes. Then, fixed cells on coverslips 
were washed three times with PBS and permeabilized using 0.05% Tween in PBS for 10 minutes 
at room temperature. For visualization of entotic events, cells were incubated with Alexa Fluor 
555-phalloidin (Invitrogen) or Alexa Fluor 488-phalloidin (Invitrogen) at 1: 500 in PBS overnight 
at 4 °C to label F-actin and DAPI (Sigma-Aldrich) to label nuclei was used at 1:10 000 for 20 
minutes at room temperature. When necessary, after permeabilization, cells were blocked using 
5% BSA in PBS-T for 1 hour at room temperature followed by the incubation with the primary 
antibodies overnight as described in the Immunofluorescence protocol (Section 3.4.1).  
To quantify entotic events, images were acquired with the LSM 700 and the LSM 800 confocal 
laser scanning microscopes (Carl Zeiss) using the Z-stack setting of the ZEN software (Carl Zeiss). 
Entotic cells and the total number of cells were quantified using the ZEN software (Carl Zeiss) 
and analyzed with ImageJ/Fiji software (National Institute of Health). For all entosis 
quantifications, at least 600 cells were quantified from 8 different visual fields for each coverslip 
and assays were performed at least three times to statistically analyse the data using Prism 6 
(GraphPad Software).  
3.5.2. 2D invasion assays on a matrix 
To study amoeboid blebbing invasion, A375-M2 melanoma cells were seeded on top of a matrix 
in a 8-well µ-slide (Ibidi) which was previously coated either with fibrillar bovine Collagen (2.4 
µg/ml, Advanced Biomatrix) diluted with 10X MEM and HEPES buffer or with Matrigel (2.5 
µg/ml, Corning) diluted in DMEM medium and then incubated for 30 minutes at 37 °C before 
plating the cells. After seeding the cells on the matrix for 1 hour at 37 °C in a 5% CO2 atmosphere, 
A375-M2 cells were tracked over a time period of 16 hours with the time-series and Z-stack 
setting of the ZEN software at the LSM 700 confocal microscope using the 40X oil objective (Carl 
Zeiss) in a 5% CO2 incubation system (Pecon, CO2 module S1). For analysis of cell morphology, 
percentage of elongated or rounded cells was assessed after plating the cells on a matrix for 16 
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hours using ImageJ/Fiji software (National Institute of Health). Other parameters like cell 
roundness was also evaluated using ImageJ/Fiji software (National Institute of Health). 
3.6. RNA analysis 
The analysis of the siRNA knockdown efficiency and the mRNA transcript level expressed for 
actin-MRTF/SRF target genes were based on the extraction of RNA from the cells, followed by 
synthesis of cDNA and quantified by real time PCR (qPCR) as described in the Figure 19.  
 
Figure 19: qPCR gene expression experimental workflow. 
3.6.1. RNA isolation from cells 
For total RNA extraction, cells were washed with PBS and directly lysed in the 6-well plate by 
adding 1 ml of Trizol reagent (Peqlab) for each well according to the manufacturer´s instructions. 
Then, cells were collected in a 1.5 ml eppendorf tube, incubated for 5 minutes at room 
temperature to allow complete dissociation of nucleoprotein complex and 200 µl chloroform 
was added, followed by 15 seconds of intensive vortexing and afterwards, samples were 
incubated for 10 minutes at room temperature. Phase separation was achieved by 
centrifugation at 12000 g for 15 minutes at 4°C. The RNA found in the upper aqueous phase was 
carefully transferred to a new 1.5 ml eppendorf tube and mixed with 500 µl isopropanol to 
precipitate the RNA. After 10 minutes incubation at room temperature, samples were 
centrifuged at 12 000g for 15 minutes at 4 °C to pellet the RNA. Finally, the RNA pellet was 
washed with 75% ethanol and pelleted at 12000 g for 5 minutes at 4°C, then dried at room 
temperature and dissolved in 20 µl RNase free H2O. Samples were stored at -80 °C. All the steps 
must be performed RNA-free until cDNA is obtained on the next phase.  
3.6.2. Reverse Transcription of total RNA 
Reverse transcription was performed using reverse transcriptase enzymes to convert RNA into 
their complementary DNA (cDNA). After RNA extraction from the cells, 500 ng RNA in a total 
volume of 10 µl were incubated with 1 µl of Random Hexamer Primer (100 µM, Thermo 
Scientific) for 5 minutes at 65 °C using a Thermal Cycler (Biometra). This step was followed by 
PCR with a master mix containing: 2 µl 10 mM dNTPs (Promega), 1 µl RiboLock Ribonuclease 
Inhibitor (Thermo Scientific), 1 µl RevertAid Reverse Transcriptase (Thermo Scientific) and 6 µl 
5x Reverse Transcriptase buffer (Thermo Scientific). The PCR reaction was filled up to a final 
volume of 19 µl. This master mix was gently mixed and 19 µl were pipetted into each RNA/primer 
reaction tube on ice. At the end, the samples were transferred to the Thermal Cycler Gene Amp 
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PCR System 9700 (Applied Bioystems) to start the PCR for cDNA preparation with the following 
program: 
Table 14: PCR program for cDNA synthesis 
 
 
 
 
 
3.6.3. Quantitative real time PCR (qPCR) 
After cDNA synthesis, the quantitative real time PCR (qPCR) was performed with Real Time 
Quantitative Thermal Cycler (Bio-Rad) using a reaction mixture with SYBR Green as a fluorescent 
dye (Bio-Rad). 
qPCR is based on the same principle as conventional PCR and allows the quantification of the 
final DNA after each amplification step. The total amount of PCR product is detected by 
measuring the fluorescence intensity at the end of each cycle. For the PCR reactions, first the 
cDNA from the reverse transcription product was diluted 1:10 and 5 µl of the cDNA were directly 
pipetted to the 96-well qPCR plate. Then, a master mix reaction was prepared for each primer 
pair containing (per sample): 12.5 µl SYBR-Green (Bio-Rad), 1 µl forward primer and reverse 
primer (100 nM, Sigma-Aldrich), and 9 µl RNAse-free H2O. A list of the qPCR primers sequences 
(Sigma-Aldrich) used in this work is shown in Table 15 and the qPCR program (Bio-Rad) used is 
described in Table 16. 
Table 15: qPCR primers sequences  
Name Sequence 5’-->3’ 
TATA-binding protein fwd 5′-TGCACAGGAGCCAAGAGTGAA-3′ 
TATA-binding protein rev 5′-CACATCACAGCTCCCCACCA-3′ 
hSRF fwd  5′-CAGATCGGTATGGTGGTCGG-3′ 
hSRF rev 5′-GTCAGCGTGGACAGCTCATA-3′ 
hEzrin fwd 5′-TAAGGGTTCTGCTCTGACTCCA-3′ 
hEzrin rev 5′-GCTCTGCATCCATGGTGGTAA-3′ 
hMRTF-A fwd 5′-CATGAGTCCCAGGGTTCTGT-3′ 
hMRTF-A rev 5′-ACTTGGCAGTGGGGATAGTG-3′ 
hMRTF-B fwd 5′-ACATTCGCCCTTTCTTGCAGT-3′ 
hMRTF-B rev 5′-TCCGAGATTGCCATCTTATTGTC-3′ 
hRadixin fwd 5′-CCATATTGCCGAGCTGTCTG-3′ 
hRadixin rev 5′-GGCAAATTCCAGCTCAGCAT-3′ 
hMoesin fwd 5′-ATCCAAGCCGTGTGTACTGC-3′ 
hMoesin rev 5′-AAATAGCTGCTTCCCGGTGG-3′ 
hCYR61 fwd 5′-GTGACGAGGATAGTATCAAGGACC-3′ 
Steps Temperature (°C) Time (sec) 
1 25°C 10 min 
2 42 °C 60 min       
3 70 °C 10 min 
4 +4°C  
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hCYR61 rev 5′-ATTTCTGGCCTTGTAAAGGGTTG-3′ 
h_c-Fos fwd 5′-CTCTCTTACTACCACTCACCCGC-3′ 
h_c-Fos rev 5′-GGTCCGTGCAGAAGTCCTGCG-3′ 
hIntegrin B1 fwd 5′-CCGCGCGGAAAAGATGAA-3′ 
hIntegrin B1 rev 5′-ACATCGTGCAGAAGTAGGCA-3′ 
hMyosin fwd  5′-TCCCCGCTGGGAATGGTC-3′ 
hMyosin rev  5′-CTTATCGGCAGCTTGCTGTG-3′ 
hMMP-9 fwd 5′-CGACGTCTTCCAGTACCGAG-3′ 
hMMP-9 rev 5′-TTGTATCCGGGCAAACTGGCT-3′ 
hmDia1 fwd 5′-GTCAGGCTTGCGGGATATG-3′ 
hmDia1 rev 5′-TTCAGCACCAAATGTTTGCAC-3′ 
hRac-1 fwd 5′-CACCGAGCACTGAACTTTGC-3′ 
hRac-1 rev 5′-CGGGAGGCTGTTCTGCTTTA-3′ 
hRhoA fwd 5′-GTCCACGGTCTGGTCTTCAG-3′ 
hRhoA rev 5′-CAGCCATTGCTCAGGCAAC-3′ 
hMLC2 fwd 5′-TGTCAGGCAGATCTGTGACG-3′ 
hMLC2 rev 5′-GGTTATACCTCCGTGCCAGG-3′ 
 
Table 16: qPCR program 
Gene expression analysis was then evaluated by determining the ratio between the amount of 
target gene of interest and an endogenous reference gene which is equally expressed in all 
samples. Relative mRNA levels were quantified using the delta cycle threshold (ΔΔCT) method 
normalized to the TATA-binding protein (TBP) cDNA. To calculate the fold change in the target 
gene relative to the TBP control gene is determined by the following equation: 
Fold change = 2 -Δ(ΔCT)  
where 𝛥𝐶𝑇 =  𝐶𝑡 target gene –  𝐶𝑡 TBP 𝑎𝑛𝑑 𝛥(𝛥𝐶𝑇)  =  𝛥𝐶𝑡 interest cDNA −𝛥𝐶𝑡 control cDNA  
3.7. Protein analysis 
3.7.1. Western Blotting 
Proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) according to their molecular weight with the Mini-PROTEN Tetra Cell System (Bio-Rad). 
Sample preparation started with the cell lysis step by adding 2x Laemmli Buffer (Table 4) directly 
to the cells to denature their proteins. After protein denaturation, cell lysates were then 
 Step Temperature (°C) Time 
1 Initial denaturation 95 3 min 
2 Denaturation 95  10 s    Steps 2-4 40 cycles 
3 Annealing 60  30 s 
4 Elongation 72  30 s 
5 Final elongation 95 2 min 
6 Melting curve 55→ 95 10 s 
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collected in a 1.5 ml Eppendorf tube and boiled for 10 minutes at 95 °C and subsequently lysates 
were centrifuged at 12 000 g for 10 minutes. Afterwards, samples were immediately loaded onto 
an SDS-PAGE gel or stored at -20°C. To run SDS-polyacrylamide gels, separating gels were cast 
in different concentrations of 6%, 8%, 10% or 15% according to the protein size and 6% for the 
stacking gel. Then, cell lysate samples and the Page-ruler pre-stained protein size ladder 
(Thermo Scientific) were loaded into the wells and SDS-polyacrylamide gels were run using 
constant voltage (80 V for stacking gel and 120 V for separating gel) to electrophoretically 
separate the proteins. Next, the separated proteins were transferred to a 0.45 µm nitrocellulose 
blotting membrane (GE Healthcare) using the Mini Trans-Blot Electrophoretic Cell system (Bio-
Rad) filled with the Western blot transfer buffer (Table 4) applying constant 350 mA for 90 
minutes on ice. After protein transfer, the nitrocellulose membranes were incubated in blocking 
buffer (Table 4) for 1 hour at room temperature. This blocking step was followed by incubating 
the different primary antibodies (Table 17) diluted in the blocking buffer with the membranes 
on a shaker overnight at 4°C. After washing the membranes three times with TBST buffer (Table 
4) for 10 minutes, the secondary HRP-conjugated antibodies diluted (Table 17) in the blocking 
buffer were incubated for 1 hour at room temperature. Membranes were washed three more 
times with TBST before developing them.  
Enhanced chemiluminescence (ECL, Table 4) was used to detect the antibody-labelled protein 
bands on Medical X-ray films (Kodak Film) which were exposed on top of the membrane at 
different time points in a dark room and developed with the X-ray film processor (Medical 
Index). The primary and secondary antibodies dilutions used on this work are listed in the Table 
17:  
Table 17: Antibodies used for Western Blot 
Primary Antibody Dilutions 
Goat anti-MRTF-A (C-19) 1:200 
Rabbit anti-SRF (G-20) 1:1000 
Mouse anti-Ezrin 1:1000 
Rabbit anti-MRTF-B 1:1000 
Rabbit anti-tubulin 1:5000 
Rabbit anti-Rac-1 1:500 
Rabbit anti-phospho-myosin light 
chain 2 
1:500 
Mouse anti-mDia1 1:1000 
Mouse anti-Integrin β1 1:1000 
Mouse anti-GFP 1:1000 
Secondary Antibody  
Goat anti-rabbit IgG HRP 1:5000 
Sheep anti-mouse IgG HRP 1:5000 
Anti-goat IgG HRP 1:5000 
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Donkey anti-goat IgG HRP 1:10000 
 
3.7.2. Reporter gene analysis 
MRTF/SRF luciferase reporter assay was assessed for reporter gene analysis where the 
transcriptional activity of the reporter gene under control of the SRF promoter can be measured. 
In this work, cells were either transiently transfected with the reporter gene constructs pRL-TK 
(Promega) and the expression vector pGL3D.AFOS (R. Treisman, The Francis Crick Institute, 
London, UK) (Mohun, Garrett, and Treisman 1987) or a stable cell line was generated using the 
FUGW lentiviral system where the SRF promoter, 3D.Aluc (Geneste, Copeland, and Treisman 
2002), from the pGL3D.AFOS vector was previously cloned into the lentivirus as explained at the 
Section 3.3.1.  
The reporter pGL3D.AFOS vector presents the c-Fos promoter and three copies of the serum 
response element (SRE) allowing the SRF-dependent expression of the Firefly luciferase. The co-
transfected control vector pRL-TK (Promega) shows Renilla luciferase expression under the 
control of the viral thymidine kinase promoter. Firefly luciferase activity was normalized to the 
control reporter pRLTK Renilla luciferase expression. 
To generate a stable MCF10A cell line under the control of the MRTF-SRF promoter, lentiviral 
luciferase reporter gene constructs (Figure 18) were cloned using the FUGW (D. Oliver, 
University of Marburg, Germany) lentiviral system where the MRTF-SRF promoter 3D.Aluc was 
linked to GFP and inserted at the FUGW vector replacing its promoter as explained in detail at 
the section 3.3.1. 
Transiently transfected cells or stable cells expressing the SRF luciferase promoter were treated 
under the desired conditions for each assay and then SRF luciferase activity was quantified 
(Figure 20). For that, cells were lysed with 200 µl Triton lysis buffer (Baker and Boyce 2014) on 
ice and collected in 1.5 ml Eppendorf tube, followed by a 10 minutes centrifugation at 13 000 
rpm at 4°C. To measure the luciferase activity, first 50 µl Firefly assay buffer (Baker and Boyce 
2014) were added to 10 µl of cell lysate, and the first measurement was assessed using a 
Luminoskan TM Ascent Microplate Luminometer (Thermo Scientific) with the Ascent Software 
(Thermo Scientific). A second measurement was carried out by adding 75 µl Renilla assay buffer 
(Baker and Boyce 2014) to the previous wells and finally, the firefly values were normalized to 
the renilla signal. 
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Figure 20: MRTF-SRF luciferase reporter gene expression. This scheme represents the MRTF-SRF driven 
luciferase reporter gene. SRF reporter gene assays were performed by measuring firefly luciferase activity 
in cells under the control of the MRTF/SRF luciferase reporter. This reporter gene contains the SRF 
promoter from the pGL3D.AFOS vector. This image was adapted from (Soto Hinojosa et al. 2017). 
3.8. Statistical analysis 
The statistical analysis of the data was done using Prism 6 (GraphPad Software). Data analysis is 
shown as mean ± SD and data distribution was assumed to be normal. Statistical significance 
was assessed as indicated for each experiment either with the unpaired Student´s t test for the 
comparison of two conditions or the ANOVA test for the comparison of several conditions. 
Statistical differences were judged as significant at *, P < 0.05; **, P < 0.01; ***, P < 0.001; and 
****, P < 0.0001. 
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4. Results 
4.1. Transcriptional regulation of the MRTF/SRF pathway during PM blebbing 
Non-apoptotic plasma membrane blebbing is enhanced by matrix deadhesion and as a 
consequence, cells will potentially undergo bleb-associated cell motility such as entotic invasion 
and amoeboid blebbing invasion (Figure 31 A). Hence, our aim was to elucidate the underlying 
signaling pathway controlling plasma membrane (PM) blebbing (Figure 21 A) and further the 
bleb-dependent mode of invasion known as entosis (Figure 21 B). 
Live cell imaging allowed us to investigate the regulation of actin dynamics during plasma 
membrane blebbing. Thus, characterization and further analysis of bleb dynamics was 
performed to study the bleb cycle in detail (Figure 21 A) and the importance of non-apoptotic 
PM-blebbing for bleb-associated cell motility, such as entotic cell-in-cell invasion (Figure 21 B). 
To examine sustained PM blebbing and subsequent entosis, human breast epithelial MCF10A 
cells were seeded on poly-HEMA coated dishes, which are known to induce blebbing and entosis 
by preventing cellular attachment (Overholtzer et al. 2007). 
 
Figure 21: Characterization of plasma membrane blebbing. (A) Bleb cycle in the human breast epithelial 
cell line MCF10A co-expressing LifeAct-mCherry (red) to label the actin cytoskeleton and the ERM protein 
Ezrin-GFP (green). Arrows indicate the bleb cycle for individual blebs over time. (B) MCF10A cells in 
suspension stably co-expressing the nuclear marker H2B-mCherry (red) with Ezrin-GFP (green) were 
monitored to analyze blebbing and subsequent entotic invasion. This time series reveals the importance 
of plasma membrane blebbing as the driving force for entosis. Scale bars, 5 µm. 
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4.1.1. Plasma membrane blebbing is affected in the absence of SRF 
To study the impact of the MRTF/SRF signaling pathway on plasma membrane blebbing, our first 
approach was to analyze the effects of Serum Response Factor (SRF) in cells undergoing PM-
blebbing. Therefore, bleb dynamics were evaluated upon interfering with MRTF/SRF in human 
epithelial breast cells MCF10A. First, control or SRF-silenced MCF10A cells stably expressing GFP 
(Figure 22 C) were plated on poly-HEMA-coated dishes to induce PM blebbing and imaged over 
time to examine bleb dynamics (Figure 22 A). Here, we observed that SRF-depleted cells showed 
a different blebbing phenotype, in which blebs were bigger and the bleb cycle was slower 
compared to the control cells (Figure 22 A-B), suggesting that bleb dynamics are affected in the 
absence of SRF.  
Different parameters were analyzed in order to quantify the observed PM-blebbing phenotype 
in the absence of SRF, including the bleb cycle dynamics, the bleb size and the ratio of blebbing 
and non-blebbing cells. The maximum bleb expansion length was measured and indeed, our 
data showed that SRF-depleted MCF10A cells produced bigger blebs than control cells in 
suspension ( Figure 22 D). Then, we focused on bleb dynamics and followed in detail the bleb 
cycle for individual blebs over time quantifying expansion and retraction times. Interestingly, 
our data showed that bleb retraction is significantly prolonged in the absence of SRF (Figure 22 
B and E). As a consequence, the total bleb cycle time was increased in SRF-depleted cells, 
whereas bleb expansion remained unaffected in the absence of SRF (Figure 22 B and E). 
Consistent with this, we found that SRF-depleted cells presented less blebbing activity compared 
to cells treated with control siRNA (Figure 22 F). Overall these data suggest that functional non-
apoptotic PM blebbing is impaired in the absence of SRF, indicating that SRF is required for 
efficient bleb retraction and dynamic PM blebbing. 
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Figure 22: Non-apoptotic blebbing phenotype is impaired in SRF-depleted cells. (A) Time-lapse imaging 
of MCF10A cells stably expressing GFP (green) transfected with control or SRF siRNAs and seeded on poly-
HEMA coated dishes to analyze bleb dynamics. Arrows indicate the bleb cycle for individual blebs over 
time. Time is indicated in seconds. Scale bars, 5 µm. (B) Live MCF10A cells stably expressing GFP, treated 
with the indicated siRNAs plated on poly-HEMA culture dishes to monitor rapid plasma membrane 
blebbing. Time is indicated in seconds. Areas marked by white boxes are shown magnified over time to 
highlight expansion and retraction of individual blebs (indicated by asterisks). Scale bars, 5 µm (overview) 
and 2 µm (magnification). (C) Western Blot demonstrating SRF knockdown efficiency in MCF10A cells 
stably expressing GFP. Tubulin served as loading control. (D) MCF10A cells stably expressing GFP 
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transfected with indicated siRNAs were monitored over time to quantify the maximum bleb expansion 
length for individual blebs. Errors bars indicate SD and asterisks indicate statistical significance (****, P < 
0.0001). (E) Quantification of bleb dynamics in blebbing cells stably expressing GFP. MCF10A cells treated 
with indicated siRNAs to quantify time for expansion, retraction and total bleb cycle of individual blebs. 
At least 60 blebs and 15 cells per condition were measured. Errors bars indicate SD and asterisks indicate 
statistical significance (****, P < 0.0001). ns indicates no significance (P ≥ 0.05). (F) Blebbing phenotypes 
were quantified in MCF10A cells stably expressing GFP treated with indicated siRNAs. At least 100 cells 
were quantified for each condition from 6 independent experiments. Errors bars indicate SD and asterisks 
indicate statistical significance (*, P < 0.05).  
4.1.2. Cortical contractility and PM blebbing regulate nucleocytoplasmic MRTF-A 
shuttling 
Myocardin-related transcription factor A (MRTF-A) is a well-known actin-regulated 
transcriptional coactivator of Serum Response Factor (SRF). Given our previous observation 
suggesting a potential link between SRF transcription and regulation of bleb dynamics, we next 
investigated the effects of the SRF transcriptional coactivator MRTF-A in continuous plasma 
membrane blebbing.  
Subcellular MRTF-A localization is dependent on the G-actin concentration, and for instance the 
formation of F-actin contributes to less G-actin, which results in nuclear MRTF-A translocation. 
Nuclear MRTF-A accumulation is promoted upon release of G-actin, which can occur due to actin 
polymerization leading to SRF-dependent gene expression (Vartiainen et al. 2007; Baarlink, 
Wang, and Grosse 2013; Mouilleron et al. 2011). Serum stimulation was shown to trigger nuclear 
MRTF-A accumulation inducing nuclear actin polymerization (Miralles et al. 2003; Baarlink, 
Wang, and Grosse 2013). Therefore, we confirmed endogenous MRTF-A nuclear accumulation 
in response to serum stimulation in human MCF10A cells (Figure 23 B) reproducing the results 
observed in mouse fibroblast NIH3T3 cells (Miralles et al. 2003). Thus, our data indicate that the 
serum response also mediates nucleocytoplasmic MRTF-A shuttling in MCF10A cells. 
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Figure 23: Serum induces nucleocytoplasmic MRTF-A shuttling in MCF10A cells. (A) Schematic 
representation of the MRTF-A RPEL domains tagged to two GFPs. The RPEL motif has been shown to be 
sufficient to allow nucleocytoplasmic MRTF-A shuttling upon serum stimulation. (B) Immunolabelling of 
endogenous MRTF-A (green), nuclei (DAPI, blue) and F-actin (Phalloidin, red) of MCF10A cells under 
starving conditions or upon 15 minutes of 20% serum (FCS) stimulation as indicated. Scale bars, 10 µm.  
We next evaluated whether non-apoptotic plasma membrane blebbing affects MRTF-A 
subcellular distribution. MCF10A cells stably expressing MRTF-A were generated via viral 
transduction using either the MRTF-A RPEL domain or the full-length MRTF-A. The RPEL motif of 
MRTF-A has been reported to be sufficient to control nucleocytoplasmic shuttling of MRTF-A 
upon serum stimulation (Guettler et al. 2008). Hence, the full-length MRTF-A or the RPEL domain 
were linked to one or two GFP sequences into a lentiviral vector to generate a stable MCF10A 
cell line inducibly expressing the full-length MRTF-A-GFP or constitutively expressing RPEL-2GFP, 
respectively (Figure 23 A). 
To analyze MRTF-A subcellular localization during induced plasma membrane blebbing, MCF10A 
cells stably expressing either the RPEL domain or full length MRTF-A were plated on poly-HEMA 
culture dishes to induce matrix deadhesion, which in turn triggers blebbing activity (Figure 24 
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A). Cells were imaged with a confocal microscope to monitor MRTF-A localization over time 
during PM blebbing. Notably, we observed that dynamic nucleocytoplasmic MRTF-A shuttling is 
blebbing dependent, whereby blebbing cells present nuclear MRTF-A and non-blebbing cells 
show cytoplasmic MRTF-A localization (Figure 24 B and D). Surprisingly, this rapid dynamic 
process shows cells initiating blebbing activity with nuclear MRTF-A accumulation and within 
minutes cells eventually stop blebbing leading to MRTF-A translocation to the cytoplasm (Figure 
24 B and D, arrows indicate shuttling). To verify our findings, the subcellular distribution of 
MRTF-A or RPEL domain was quantified in blebbing cells and compared with non-blebbing cells. 
Consistently, quantification results showed blebbing cells with mostly predominant nuclear 
MRTF-A accumulation, while non-blebbing cells presented cytoplasmic or pan-cellular MRTF-A 
localization (Figure 24 C and E). These data reveal a striking correlation between PM blebbing 
and dynamic nuclear MRTF-A accumulation, indicating that nucleocytoplasmic MRTF-A 
translocation depends on blebbing activity.  
To further investigate a link between the contractile actin cortex and MRTF-A localization in 
induced PM blebbing, Blebbistatin was used to disrupt blebbing activity. This drug is a small 
molecule inhibitor of non-muscle myosin IIA known to block plasma membrane blebbing 
(Cheung et al. 2002; Straight et al. 2003; Limouze et al. 2004; Guillaume T Charras et al. 2006; 
Norman, Sengupta, and Aranda-Espinoza 2011). Drug treatment with Blebbistatin resulted in 
complete MRTF-A translocation to the cytoplasm within 30 minutes (Figure 25 A). Subcellular 
MRTF-A localization was then quantified to validate our data in response to 100 µM Blebbistatin 
treatment for 30 minutes. The results show that cells blebbing activity ceased triggering MRTF-
A export to the cytoplasm (Figure 25 B).  
We report here that PM blebbing together with the contractile actin cortex control dynamic 
MRTF-A nucleocytoplasmic translocation, which in turn suggest that MRTF/SRF might be 
involved in sustained long-term PM blebbing. 
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Figure 24: Plasma membrane blebbing triggers dynamic nuclear MRTF-A accumulation. (A) This cartoon 
illustrates the work flow to study bleb dynamics. Adherent MCF10A cells are detached and subsequently 
plated on poly-HEMA coated dishes preventing cellular attachment. As a result of a lack of matrix 
adhesion, plasma membrane blebbing is eventually induced. (B) Live MCF10A cells stably expressing RPEL-
2GFP (green) plated on poly-HEMA were monitored over time to analyze RPEL subcellular localization. 
Differential interference contrast (DIC) was added for each frame to visualize plasma membrane blebbing. 
Arrows indicate RPEL-2GFP shuttling cells. Scale bars, 10 µm. (C) Quantification of RPEL-2GFP subcellular 
localization for blebbing and non-blebbing MCF10A cells stably expressing RPEL-2GFP plated on poly-
HEMA. At least 100 cells from four independent experiments were quantified. Localization was defined 
as predominantly cytoplasmic (C), pancellular (N/C), or nuclear (N). Error bars indicate SD. (D) Time-lapse 
imaging of MCF10A cells stably co-expressing MRTF-A-GFP (green) together with LifeAct-mCherry (red) 
Results 
 
77 
 
seeded on poly-HEMA coated dishes to monitor MRTF-A-GFP subcellular localization over time. LifeAct-
mCherry expression labelling the actin cytoskeleton allows visualization of blebs. Arrows indicate a cell 
with dynamic nucleocytoplasmic MRTF-A shuttling. Scale bars, 5 µm. (E) Quantification of subcellular 
distribution of MRTF-A-GFP in blebbing and non-blebbing MCF10A cells stably expressing GFP-tagged 
MRTF-A on poly-HEMA as in C. At least 180 cells from six independent experiments were quantified. 
Localization is defined as described in C. Error bars indicate SD. 
 
Figure 25: Blebbistatin treatment blocks blebbing activity leading to MRTF-A cytoplasmic export. (A) 
Time-lapse imaging of MCF10A cells stably co-expressing MRTF-A-tagged GFP (green) and LifeAct-tagged 
mCherry (red) plated on poly-HEMA were treated with the non-muscle myosin IIa inhibitor Blebbistatin 
(100 µM) at 0 min and MRTF-A-GFP subcellular distribution was monitored over time as indicated. LifeAct-
mCherry is included to visualize plasma membrane blebbing and reveals inhibition of blebbing activity. 
Asterisks indicate cells with cytoplasmic export of MRTF-A. Scale bars, 5 µm. (B) Quantification of MRTF-
A-GFP subcellular distribution after treatment with 100 µM Blebbistatin for 30 minutes in MCF10A cells 
compared to non-treated cells. At least 200 cells from six independent experiments were quantified. 
Localization was defined as cytoplasmic (C), pancellular (N/C), or nuclear (N). Error bars indicate SD. 
4.1.3. MRTF/SRF transcriptional activity is induced by sustained PM blebbing 
These findings suggested that the MRTF/SRF pathway appears to play a role in PM blebbing. Our 
next goal was to investigate the direct link between induced continuous blebbing and MRTF/SRF 
transcription. Therefore, we examined whether matrix deadhesion induced PM blebbing directly 
stimulates MRTF/SRF activity and if SRF transcription is affected upon PM blebbing. Consistent 
with our previous experimental model, plasma membrane blebbing was induced by plating the 
cells on poly-HEMA coated culture dishes to prevent cellular adhesion. Consequently, cells will 
remain in suspension and present blebbing activity, and eventually entotic events will take place 
(Figure 24 A). 
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SRF luciferase reporter genes assays were assessed to test our hypothesis and understand 
whether sustained long-term plasma membrane blebbing conditions regulate actin-mediated 
MRTF/SRF transcriptional activity. For that, the SRF reporter gene tagged to GFP was cloned into 
the lentiviral vector FUGW and then MCF10A cells were transduced to stably express the SRF 
reporter gene linked to GFP. The luciferase reporter gene construct was originally closed under 
the control of the SRF promoter 3D.Aluc (Geneste, Copeland, and Treisman 2002) generating 
the SRF luciferase reporter gene, which allows us to measure accumulation of luciferase protein 
under the SRF promoter by luminescence measurement. 
Serum stimulation assays were performed to validate the MCF10A cell lines stably expressing 
the SRF-luciferase reporter. As expected, the negative control cell line without a promoter 
showed no SRF luciferase activity (Figure 26 A), whereas the cell line expressing the hUBc 
promoter from the lentiviral FUGW showed constitutively active SRF luciferase activity either 
with or without serum stimulation (Figure 26 A). Importantly, the CArG-(MRTF/SRF)-driven cell 
line showed a remarkable increase of luciferase activity in response to serum (Figure 26 A) 
allowing the determination of the activity of the MRTF/SRF transcriptional pathway by 
luminometric quantification of the luciferase protein.  
We next aimed to investigate whether sustained long-term blebbing enhances SRF luciferase 
activity. To test this hypothesis, we evaluated SRF induction in MCF10A cells stably expressing 
SRF luciferase reporter cultured on poly-HEMA for longer periods of time. Our data showed a 
notable increase of SRF luciferase activity upon induced sustained long-term PM blebbing over 
time under these conditions (Figure 26 B), suggesting that SRF luciferase activity is stimulated in 
response to continuous dynamic PM-blebbing activity. Consistent with this, qPCR-based analysis 
of SRF transcript levels were assessed to confirm our observations and, similarly, we found that 
SRF is upregulated upon induced PM-blebbing (Figure 26 C), indicating MRTF/SRF activity in 
response to blebbing, since SRF is a target gene of its own transcriptional activity (Esnault et al. 
2014). Taken together, these data suggest that long-term non-apoptotic PM blebbing is coupled 
to nuclear MRTF-A shuttling, which enhances upregulation of SRF expression on a transcript as 
well as protein level. 
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Figure 26: Sustained long-term PM blebbing enhances MRTF/SRF activity. (A) To validate the MCF10A 
cell lines stably expressing different luciferase reporter constructs, cells were either serum deprived for 
24h followed by stimulation with 20% serum for 7h or serum deprived for a total time of 31h. Then, the 
amount of firefly luciferase was measured luminometrically to assess relative levels of SRF luciferase 
activity. Results are shown from one experiment. (B) The amount of firefly luciferase was measured in 
MCF10A cells stably expressing the SRF luciferase reporter, seeded on poly-HEMA for indicated periods 
of time. Results are shown as means from four independent experiments. Error bars indicate SD. Asterisks 
indicate statistical significance (***, P < 0.001). (C) Relative SRF mRNA levels were assessed by 
quantitative RT-PCR from MCF10A cells, which where adherent (ctrl.) or plated on poly-HEMA for the 
indicated periods of time to induce PM blebbing. MCF10A cells were transfected with either control or 
SRF siRNA prior to plating. Note SRF mRNA upregulation upon PM blebbing and validation of SRF 
knockdown. Results are shown as means from three independent experiments. Error bars indicate SD and 
asterisks indicate statistical significance (**, P < 0.01; ***, P < 0.001; ****, P < 0.0001). 
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4.1.4. Dynamic PM blebbing induces MRTF/SRF transcriptional activity leading to 
Ezrin upregulation 
Given our findings that MRTF/SRF transcriptional activity is dependent on PM blebbing, we next 
aimed to identify the specific target genes involved in our bleb-dependent invasion model 
(Figure 31 A). ERM proteins are known to be involved during the bleb cycle to reassemble the 
actin cortex  (G. Charras and Paluch 2008), thereby we investigated whether ERM proteins could 
be potential MRTF/SRF target genes under our sustained blebbing conditions. 
Our findings so far revealed that expression of the ERM protein Ezrin is robustly upregulated on 
a protein and transcript level upon induced PM-blebbing (Figure 27 A-C). Hence, we evaluated 
whether MRTF/SRF is involved in Ezrin upregulation. For that, we employed knockdown of SRF 
or double knockdown of MRTF-A and B in MCF10A cells. Surprisingly, induction of Ezrin 
transcript levels is reduced in the absence of SRF or MRTF-A/B (Figure 27 A-B), indicating that 
blebbing stimulates upregulation of Ezrin in a MRTF/SRF-dependent manner.  
Even though these data suggest that sustained PM blebbing induces MRTF/SRF-dependent 
upregulation of Ezrin expression, we further tested whether other ERM proteins and other actin-
associated proteins are also potential target genes to confirm our hypothesis and determine the 
specificity towards Ezrin. Nonetheless, our results show that Radixin, Moesin or Myosin are 
neither upregulated by induced PM-blebbing nor are dependent on the MRTF/SRF signaling 
pathway (Figure 27 D-F) demonstrating Ezrin exclusivity. Thus, MRTF/SRF induction upon 
induced PM-blebbing appears to be specific for the metastatic ERM protein Ezrin.  
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Figure 27: PM blebbing triggers MRTF/SRF-dependent upregulation of the ERM Ezrin. (A, B, D, E, F) 
Relative mRNA levels from MCF10A cells either attached (ctrl.) or plated on poly-HEMA culture dishes to 
induce blebbing for the indicated periods of time were assessed by quantitative RT-PCR. Errors bars 
indicate SD and asterisks indicate statistical significance (ns, P ≥ 0.05; ***, P < 0.001; ****, P < 0.0001). 
(A) Relative Ezrin mRNA levels from MCF10A cells transfected with control or SRF siRNA were compared 
by quantitative RT-PCR. Results are shown as the mean from three independent experiments. (B) Relative 
Ezrin mRNA levels from MCF10A cells transfected with control or combined siRNAs against MRTF-A and 
MRTF-B were compared. Results are shown as the mean from three independent experiments. (C) 
Western blot analysis showing Ezrin protein expression in MCF10A cells plated on poly-HEMA to induce 
plasma membrane blebbing for indicated durations. Tubulin served as loading control. Western blot band 
intensities were densitometrically quantified from two independent experiments using ImageJ. (D-F) 
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Relative mRNA levels of Radixin (D), Moesin (E) and Myosin (F) from MCF10A cells transfected with control 
or SRF siRNA were compared. Results are shown as the mean from three independent experiments.  
To further verify that Ezrin is upregulated in a MRTF/SRF-dependent manner during blebbing, 
the prototypic serum stimulation assay was tested in MCF10A cells. At first, we confirmed that 
the well-known SRF-inducible immediate early target genes Fos and CYR61 (O’Brien et al. 1990; 
Müller et al. 1984) were enhanced in response to serum stimulation in human MCF10A cell 
system (Figure 28 A). Our data indicate that Ezrin mRNA levels are upregulated upon serum 
stimulation, while Radixin and Moesin are not affected (Figure 28 B).  
 
Figure 28: Serum stimulation leads to upregulation of the ERM protein Ezrin. (A) Relative mRNA levels 
of Fos and CYR61 were assessed by quantitative RT-PCR from MCF10A cells maintained under serum 
deprivation conditions with 0.05% FCS for 24h, followed by serum stimulation using 20% horse serum for 
the indicated periods of time. Results are shown as the mean from three independent experiments. Error 
bars indicate SD and asterisks indicate statistical significance (****, P < 0.0001). ns indicates no 
significance (P ≥ 0.05). (B) Relative mRNA levels of Ezrin, Radixin and Moesin were assessed from MCF10A 
cells in serum-deprived conditions for 24h and then stimulated either with or without serum for the 
indicated periods of time. Results are shown as the mean from three independent experiments. Error bars 
indicate SD and asterisks indicate statistical significance (*, P < 0. 05; **, P < 0. 01). ns indicates no 
significance (P ≥ 0.05). 
Next, we were interested to confirm that plasma membrane blebbing and not matrix 
deadhesion per se is the condition that triggers nuclear accumulation of MRTF-A upon plating 
cells on poly-HEMA coated dishes. Therefore, MCF10A cells were detached and plated on poly-
HEMA to stimulate blebbing and treated either with the ROCK inhibitor Y27632 or the myosin II-
A drug Blebbistatin. Treatment with Blebbistatin is known to block blebbing activity and the 
ROCK inhibitor drug has been described to interfere with entosis (Purvanov et al. 2014). As a 
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result of drug treatments, relative SRF and Ezrin mRNA transcript levels were unaffected upon 
PM-blebbing (Figure 29 A-B). Thus, preventing blebbing inhibits SRF and Ezrin transcriptional 
upregulation, which confirms our hypothesis that matrix deadhesion triggers blebbing-inducing 
MRTF/SRF-mediated upregulation of Ezrin. Together these findings reveal that matrix 
deadhesion induces cellular blebbing, which in turn enhances MRTF/SRF-dependent 
upregulation of the specific ERM protein Ezrin.  
 
Figure 29: Detachment-induced upregulation of SRF and Ezrin depends on PM blebbing. Relative mRNA 
levels of SRF (A) and Ezrin (B) were assessed by quantitative RT-PCR from MCF10A cells cultured in 
attached conditions (ctrl.) or plated on poly-HEMA for 60 min. Cells were treated either with 10 µM ROCK 
inhibitor Y27632, 100 µM Blebbistatin or 0.1% DMSO (ctrl.) for 60 min. Results are shown as the mean 
from three independent experiments. Error bars indicate SD and asterisks indicate statistical significance 
(**, P < 0.01; ***, P < 0.001). ns indicates no significance (P ≥ 0.05).  
4.1.5. Effects of the MRTF/SRF transcriptional pathway on formin mDia1 
Previous work from our laboratory has reported the importance of the Diaphanous formin 
mDia1 downstream of Rho for bleb-associated cancer invasion (Thomas M Kitzing et al. 2007), 
as well as for functional non-apoptotic plasma membrane blebbing driving entotic cell-in-cell 
invasion (Purvanov et al. 2014).  
Therefore, we hypothesized that the actin nucleation factor mDia1 may also play a role in the 
MRTF/SRF transcriptional pathway. Hence, we assessed the protein and transcript levels of 
mDia1 in SRF-depleted MCF10A cells. However, expression levels of formin mDia1 were not 
affected in the absence of SRF (Figure 30 A-B), indicating that SRF silencing does not alter 
expression of the formin mDia1. 
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Figure 30: The MRTF/SRF pathway has no effect on formin mDia1 expression. (A) Western blot showing 
no effect on expression levels of formin mDia1 in SRF-depleted MCF10A cells and vice versa no influence 
of mDia1 depletion on protein levels of SRF. Results confirm siRNA-mediated knockdown efficiencies for 
SRF and mDia1 in MCF10A cells. Tubulin served as loading control. (B) Relative mRNA levels of SRF and 
mDia1 were assessed by quantitative RT-PCR from MCF10A cells treated either with control siRNA, siRNA 
directed against SRF or mDia1. Results are shown as the mean from three independent experiments. Error 
bars indicate SD and asterisks indicate statistical significance (***, P < 0. 001). ns indicates no significance 
(P ≥ 0.05). 
 
4.2. The importance of MRTF/SRF transcription for entotic invasion 
Given the crucial role of blebbing in driving entotic invasion (Purvanov et al. 2014), we next 
aimed to understand if MRTF/SRF transcriptional regulation is involved in bleb-associated 
entotic invasion.  
4.2.1. Role of the ERM protein Ezrin during entotic cell-in-cell invasion 
Since MRTF/SRF appears to be important in plasma membrane blebbing and to further analyze 
this process, we tested the impact of this pathway on entosis ( Figure 31 A). Although our results 
identified the ERM Ezrin as a MRTF/SRF target gene, it was unclear if Ezrin expression plays a 
role in PM blebbing and subsequent entotic invasion. It is known that ERM proteins localize at 
the cell cortex and interact with the plasma membrane and the actin cytoskeleton. Interestingly, 
previous findings showed that membrane blebbing is Ezrin-dependent and blebbing is decreased 
at the Ezrin-rich uropod-like structure during amoeboid blebbing invasion (Lorentzen et al. 
2011).  
Results 
 
85 
 
 
Figure 31: The ERM protein Ezrin is redistributed at the rear end of the invading cell. (A) This cartoon 
illustrates an experimental model to study induced plasma membrane blebbing and subsequent entotic 
invasion by plating cells on poly-HEMA to prevent cellular attachment. (B) Live MCF10A cell stably 
expressing the ERM Ezrin-tagged to mCherry (red) invading into another cell expressing Ezrin-tagged GFP 
(green) were monitored over time to visualize Ezrin distribution during cell-in-cell invasion. Note the 
polarized redistribution and enrichment of Ezrin-mCherry at the rear end of the invading cell. Time (min) 
is indicated at the upper left corner. Scale bars, 5 µm. (C) Immunolabelling of endogenous Ezrin (red), 
phospho-Ezrin/Radixin/Moesin (green) and nuclei (DAPI, blue) in MCF10A cells fixed after 4h in 
suspension to induce entotic invasion. Note the polar redistribution of Ezrin and p-ERM at the rear of the 
invading cell during cell engulfment and at the uropod-like structure phase. Scale bars, 5 µm. 
To this end, we generated a MCF10A cell line stably co-expressing GFP-tagged Ezrin (green) 
together with the nuclear marker mCherry-tagged H2B (red) to monitor Ezrin localization over 
time during entotic invasion. We observed that Ezrin is redistributed and accumulated at the 
rear end of the invading cell during advanced stages of cell-in-cell invasion, such as cell 
engulfment and at the uropod-like structure (Figure 21 B and Figure 31 B). To further confirm 
Ezrin redistribution and enrichment at the invading cell during entosis, Ezrin-GFP and Ezrin-
mCherry expressing MCF10A cells were mixed and the entosis outcome analyzed. Indeed, this 
dual color-assay confirmed polarized enrichment of Ezrin at the rear end of the invading cell that 
is driving entotic invasion (Figure 31 B).  
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To gain insights into Ezrin activation, we examined the activation state of Ezrin during the entotic 
invasion process by evaluating Ezrin’s phosphorylation state. We observed that endogenous 
phosphorylated-ERM (pERM) colocalizes with endogenous Ezrin during entotic invasion showing 
a polarized enrichment of pERM at the rear of the invading cell (Figure 31 C).  
4.2.2. Entotic invasion requires transcriptional activity and MRTF/SRF transcription 
In order to address whether transcriptional activity plays an important role for entotic invasion, 
global transcription was blocked by applying 50 µg/ml Actinomycin D (Bensaude 2011) and 
subsequently, entosis ability was quantified. First, we verified effective inhibition of 
transcription using the indicated concentration and duration of Actinomycin D treatment in a 
serum stimulation assay, which confirms the efficiency of the inhibitor, since it robustly blocks 
Fos mRNA induction (Figure 32 B). Entosis assays showed a significant decrease in entotic 
invasion upon Actinomycin D treatment compared to non-treated MCF10A cells (Figure 32 A 
and C). We then blocked translation to interfere with protein synthesis using the translation 
inhibitor Cycloheximide and studied its effects on entosis. Treatment of MCF10A cells with 100 
µg/ml Cycloheximide resulted in a complete block of entosis (Figure 32 A and C), indicating that 
both global transcription and translation are crucial events for entosis. 
SRF and its transcriptional coactivator MRTF-A are known to regulate actin-related target genes, 
but also genes fundamental for cell proliferation and tumor growth (Leitner et al. 2011; 
Ohrnberger et al. 2015; Shaposhnikov et al. 2013). Nonetheless, whether MRTF/SRF and Ezrin 
affect entotic invasion was unknown. To test if Ezrin, MRTF or SRF are required for entosis, 
MCF10A cells were silenced with siRNAs directed against Ezrin, MRTF A/B or SRF and then, 
entosis assays were performed. Our data showed successful knockdown (Figure 33 A) and 
surprisingly, that silencing of either Ezrin, MRTF A/B or SRF lead to strongly decreased entosis 
(Figure 33 B), suggesting that MRTF/SRF and Ezrin are required for entotic invasion. Taken 
together, these results indicate that global transcriptional activity and the specific MRTF/SRF 
transcriptional pathway are crucial for entotic cell-in-cell invasion. 
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Figure 32: Global transcriptional activity and translation are essential for entotic invasion. (A) MCF10A 
cells plated on ultra-low attachment culture dishes to induce cell-in-cell invasion were treated either with 
50 µg/ml Actinomycin D to test the effects of transcriptional inhibition or with 100 µg/ml Cycloheximide 
to study the effects of translational inhibition. Cells without drug treatment were used as controls. After 
drug treatment and 4h of culture in suspension, cells were fixed and labelled for F-actin with Phalloidin-
Alexa Fluor 488 (green) and nuclei with DAPI (blue). Arrows indicate entotic events. Scale bars, 10 µm. (B) 
Relative mRNA levels of serum-inducible Fos expression were assessed by quantitative RT-PCR from 
MCF10A cells. Cells were serum starved for 24h and stimulated either with or without 20% FCS for 30 min, 
then treated with or without 50 µg/ml Actinomycin D for the indicated periods of time to confirm 
transcriptional inhibition. Results are shown as the mean from two independent experiments. Error bars 
indicate SD. Asterisks indicate statistical significance (****, P < 0. 0001). ns indicates no significance (P ≥ 
0.05). (C) Quantification of entotic invasion corresponding to A. Entotic events were counted from three 
independent experiments using at least 2000 cells for each condition. Error bars indicate SD. Asterisks 
indicate statistical significance (***, P < 0.001). 
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Figure 33: Cell-in-cell invasion requires MRTF/SRF and Ezrin expression. (A) Western blot showing siRNA-
mediated knockdown efficiencies of SRF, Ezrin or MRTF-A together with MRTF-B in MCF10A cells. Tubulin 
was used as a loading control. (B) Entotic invasion quantification of MCF10A cells treated with indicated 
siRNAs for 72h before being analyzed for entosis. Entotic events were counted from three independent 
experiments and at least 800 cells for each condition were quantified. Error bars indicate SD. Asterisks 
indicate statistical significance (***, P < 0.001; ****, P < 0.0001). 
Next, we elucidated the effect of MRTF-A on entotic invasion. Given the association between 
MRTF/SRF with entosis, we determined whether overexpressing MRTF-A could enhance entotic 
invasion. Constitutively active MRTF known as ΔN-MRTF was stably expressed tagged to GFP in 
transduced MCF10A cells and entosis ability was compared with MCF10A control cells stably 
expressing GFP. MCF10A cells stably expressing ΔN-MRTF-A-GFP were induced with doxycycline 
to trigger expression of constitutively active MRTF-A. Confocal microscopy and RT-qPCR 
confirmed inducible expression and nuclear localization of ΔN-MRTF-A linked to GFP construct 
in response to doxycycline (Figure 34 A and C). Indeed, our results showed an increase of entotic 
invasion in MCF10A cells stably expressing ΔN-MRTF-A (Figure 34 B), suggesting that 
constitutively active MRTF-A enhances entosis.  
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Figure 34: Constitutively active MRTF-A promotes entotic invasion. (A) Doxycycline induction of MCF10A 
cells stably expressing an inducible ΔN-MRTF-GFP (green) was validated with confocal imaging after 
adding doxycycline for 24h (+dox) to induce expression of constitutively active MRTF-A. Cells were fixed 
and labelled for F-actin with Rhodamine-Phalloidin 555 (red) and nuclei were stained with DAPI (blue). 
Scale bar, 15 µm. (B) Quantification of entotic invasion in MCF10A cells induced to express constitutively 
active MRTF-A (ΔN-MRTF-GFP) or only GFP as control cell line. Entotic events were quantified from three 
different experiments. Error bars indicate SD and the asterisk indicates statistical significance (*, P < 0.05). 
(C) Relative mRNA levels of MRTF-A and SRF were assessed by quantitative RT-PCR from MCF10A cells 
treated with or without doxycycline to validate the doxycycline-inducible ΔN-MRTF-GFP expression. 
Results are shown as the mean from three independent experiments. Error bars indicate SD and asterisks 
indicates statistical significance (*, P < 0.05). 
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4.2.3. The MRTF/SRF pathway is crucial in the invading cell to promote entotic 
invasion 
We next investigated whether the invading or the host cell is affected by SRF depletion during 
entosis. We performed a dual-color entosis assay, in which control H2B-GFP cells (green) and 
SRF-depleted H2B-mCherry cells (red) were mixed and entotic events were quantified. This assay 
showed strongly reduced entosis in the absence of SRF in the invading cell indicating that SRF-
depleted cells failed to invade host cells (Figure 35 A). However, when SRF was silenced in host 
cells, entosis was not altered (Figure 35 A). Hence, SRF contributes to entosis and appears to be 
specifically required in the invading cell, which in turn is the cell with continuous PM blebbing 
driving entotic invasion.  
To further analyze why SRF-depleted cells fail to undergo entotic invasion, entosis events were 
monitored over time by live cell imaging. Interestingly, our data showed that SRF-depleted cells 
failed to successfully complete entotic invasion in spite of cell engulfment initiation (Figure 35 
C). Additionally, entosis quantification revealed that only 20% of initiated entotic events were 
able to complete cell-in-cell invasion in the absence of SRF, whereas roughly 80% of siRNA 
treated control cells successfully finished entosis (Figure 35 B). We defined initiation of entosis 
by an initial protrusion of one cell into another and followed them over time to assess the 
proportion of completed entotic events. These data demonstrate the importance of SRF in the 
invading cell in driving entosis, suggesting that SRF-depleted invading cells fail to produce 
enough force to invade into the host cell.  
We next examined MRTF-A subcellular localization during entotic invasion. MCF10A cells stably 
co-expressing MRTF-A-GFP (green) and the actin marker LifeAct-mCherry (red) were monitored 
over time during cell-in-cell invasion. Our results reveal the importance of nuclear MRTF-A 
localization in the invading cells before cell invasion during entotic non-apoptotic blebbing and 
before cell engulfment, while host cells predominantly showed cytoplasmic MRTF-A before 
engulfment (Figure 36 A-B). Despite prominent differences in MRTF-A localization in invading 
and host cells prior to engulfment, both cell types display a similar pattern of cytoplasmic or 
pancellular localization after engulfment (Figure 36 B). These data indicate that nuclear MRTF-A 
accumulation is required in the invading cell before cell engulfment in order to trigger entotic 
invasion.  
Results 
 
91 
 
 
Figure 35: SRF depletion specifically affects the invading cell during entotic invasion. (A) MCF10A cells 
stably expressing the nuclear marker H2B-mCherry (red) were transiently transfected with SRF siRNA 
(H2B-mCherry) for 72h, while H2B-GFP (green) expressing cells were transfected with control siRNA for 
72h. Then, equal cell numbers were mixed and plated on ultra-low attachment plates for 4h to induce 
cell-in-cell invasion. Entotic events were scored according to the indicated color combinations. Note the 
impaired invasion in SRF-silenced invading cells. At least 290 entotic events were considered from three 
independent experiments. Error bars indicate SD. Asterisks indicate statistical significance (*, P < 0. 05; 
**, P < 0. 01). ns indicates no significance (P ≥ 0.05). (B) Quantification of completed entotic invasion 
events in MCF10A cells transfected with control or SRF siRNA for 72h. Numbers represent percentage of 
successful cell-in-cell invasion of overall events, characterized by an initial cell-in-cell protrusion. At least 
40 initiated entotic invasion events were analyzed from ten independent experiments. Error bars indicate 
SD. Asterisk indicates statistical significance (**, P < 0. 01). (C) MCF10A cells stably expressing LifeAct-GFP 
(green) treated with indicated siRNAs, control or SRF, were plated on poly-HEMA coated dishes and 
monitored over time to analyze entotic invasion. Note that SRF-depleted MCF10A cells fail to complete 
entotic invasion. Scale bars, 10 µm.  
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Figure 36: Invading cells show nuclear MRTF-A localization during entosis initiation. (A) Time-lapse 
imaging of MCF10A cells stably expressing LifeAct-mCherry (red) together with MRTF-A-GFP (green) on 
poly-HEMA over time to follow MRTF-A localization during the process of cell-in-cell invasion. An invading 
cell is marked by a yellow arrow while the pink arrow indicates the corresponding host cell in individual 
frames. Scale bars, 5 µm. (B) Quantification of MRTF-A-GFP subcellular distribution before and during cell 
engulfment for the invading (inner) and the host (outer) cell as seen in A. MRTF-A subcellular distribution 
was quantified as predominant nuclear (N), pancellular (N/C) or cytoplasmic (C). At least 25 entotic events 
were considered. 
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4.2.4. Expression of the ERM protein Ezrin restores PM blebbing and entosis in SRF-
depleted cells 
Our findings show that upregulation of the ERM Ezrin depends on the MRTF/SRF transcriptional 
pathway. Therefore, we assessed the importance of Ezrin on bleb dynamics. For that, wild-type 
Ezrin-GFP was stably expressed in MCF10A cells to compare bleb dynamics with stably 
expressing GFP cells (Figure 37 A). Then, cells were treated with siRNA against SRF or control 
siRNA, and bleb dynamics were further analyzed. Western blot analysis confirmed silencing of 
SRF for both cell lines (Figure 37 B). Interestingly, we observed that the maximum bleb expansion 
length was not increased in the Ezrin-GFP-expressing cells in the absence of SRF (Figure 37 C), 
while SRF depletion strongly affected bleb dynamics generating larger blebs in control cells 
expressing GFP (Figure 37 C and Figure 22 D). Furthermore, depletion of SRF did not affect bleb 
retraction time in blebbing cells expressing wild-type Ezrin-GFP (Figure 37 D) compared to the 
control siRNA-treated cells (Figure 37 D), even though we previously observed longer bleb 
retraction time in control cells stably expressing GFP (Figure 22 E). These data reveal that 
increased wild-type Ezrin expression is sufficient to rescue SRF suppression during bleb 
dynamics. 
Our results demonstrate a novel function for Ezrin in restoring impaired plasma membrane 
blebbing in SRF-depleted cells, therefore we next tested the non-phosphorylatable mutant 
Ezrin-T567A,  which is found poorly associated to the actin cytoskeleton (Gautreau, Louvard, and 
Arpin 2000). This inactive Ezrin variant T567A was expressed tagged to GFP in MCF10A cells to 
determine its effects on bleb dynamics and entosis. Expression of the inactive Ezrin-T567A 
affected bleb dynamics. Cells produced larger blebs and showed deficient bleb retraction and 
less blebbing activity (Figure 37 A, C and E). This indicates that Ezrin-T567A expression could not 
override the lack of SRF for efficient bleb dynamics. Taken together, these results confirm that 
Ezrin activity is sufficient for functional bleb dynamics validating Ezrin as a MRTF/SRF target 
gene.  
Consistent with our data, wild-type Ezrin expression rescued entotic invasion in the absence of 
SRF (Figure 38 A), even though entosis was reduced for SRF-depleted control cells expressing 
GFP (Figure 38 A). Moreover, re-expression of the non-phosphorylatable mutant Ezrin T567A 
failed to restore entosis (Figure 38 A), indicating that wild-type Ezrin expression is crucial for 
entosis in SRF-silenced cells. We further examined the phenotype of the SRF-depleted stably 
expressing wild-type Ezrin-GFP MCF10A cells undergoing entotic invasion. We observed that 
entosis events occur in a similar manner regardless of SRF depletion upon ectopic Ezrin 
expression. Cell-in-cell invasion time was also unaffected (Figure 38 B-C). Together these 
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findings underline the importance of Ezrin expression to rescue bleb dynamics and subsequent 
entosis in the absence of SRF. 
 
Figure 37: Expression of wild type Ezrin rescues bleb dynamics in SRF-depleted cells. (A) Live MCF10A 
cells stably expressing either GFP, wild type Ezrin-GFP or the inactive mutant Ezrin-T567A-GFP treated 
with the indicated siRNAs for 72h were plated on poly-HEMA culture dishes and imaged over time to 
visualize bleb dynamics. Scale bars, 5 µm. (B) Western blot showing SRF knockdown efficiency in MCF10A 
cells stably expressing GFP, Ezrin-GFP or Ezrin-T567A-GFP. Note the detection of endogenous and 
overexpressed Ezrin. Tubulin served as loading control. (C) Quantification of maximum bleb expansion 
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length of individual blebs in MCF10A cells in A. At least 60 blebs and 15 cells were quantified for each 
condition (C-E). Errors bars indicate SD and asterisks indicate statistical significance (****, P < 0.0001). ns 
indicates no significance (P ≥ 0.05). (D) Live MCF10A cells stably expressing Ezrin-GFP treated with siRNAs 
as in A. were plated on poly-HEMA to induce blebbing and imaged over time to measure the time for 
expansion and retraction of individual blebs. Errors bars indicate SD. ns indicates no significance (P ≥ 0.05). 
(E) MCF10A cells described in A. were plated on poly-HEMA dishes to analyze the number of blebbing 
cells and non-blebbing cells. At least 100 cells were quantified for each condition from three independent 
experiments. Errors bars indicate SD and the asterisk indicates statistical significance (*, P < 0.05). ns 
indicates no significance (P ≥ 0.05). 
 
Figure 38: Ezrin expression restores entotic invasion in the absence of SRF. (A) Quantification of entosis 
in MCF10A cells stably expressing GFP, wild type Ezrin-GFP or the non-phosphorylatable mutant Ezrin-
T567A-GFP were treated with control or SRF siRNA for 72h and entotic cell-in-cell invasion events were 
quantified as percentage of total cells. Entotic events were counted from three independent experiments. 
Error bars indicate SD. Asterisks indicate statistical significance (****, P < 0.0001). ns indicates no 
significance (P ≥ 0.05). (B) Quantification of entotic invasion time in MCF10A cells stably expressing Ezrin-
GFP transfected with siRNA directed against control or SRF were monitored over time using live cell 
imaging. Ten independent entosis events were counted. (C) Live MCF10A stably expressing Ezrin-GFP 
transfected with siRNA against SRF for 72h were plated on poly-HEMA to follow the process of entotic 
invasion. Scale bars, 10 µm.  
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4.3. Regulation of the MRTF/SRF pathway in amoeboid invasion 
Given the association between the MRTF/SRF-actin regulated transcriptional feedback and a 
bleb-dependent way of invasion, entosis (Soto Hinojosa et al. 2017), we hypothesized that the 
MRTF/SRF pathway plays a role in bleb-associated amoeboid invasion. 
4.3.1. Role of SRF on amoeboid phenotype 
To study amoeboid migration, melanoma A375-M2 cells were plated on top of a matrix and cell 
morphology was monitored over time. Here, we observed two different modes of invasion, the 
most predominant was amoeboid blebbing motility, even though some of the cells also undergo 
the elongated mesenchymal type (Figure 39 A). We next tested whether MRTF/SRF plays a role 
in amoeboid blebbing invasion. Therefore, A375 cells stably co-expressing LifeAct-GFP (green) 
and H2B-mCherry (red) silenced for SRF (Figure 39 B) were imaged on top of Matrigel for 16 
hours, and their phenotype was compared with control siRNA-treated cells to study the effects 
of SRF depletion on bleb-associated migration. Importantly, we observed a switch from 
amoeboid rounded blebbing morphology to the elongated mesenchymal morphology in SRF-
depleted melanoma A375-M2 cells (Figure 39 A). After seeding melanoma cells for 16h on 2.5 
µg/ml Matrigel, elongated morphology was more predominant than the blebbing rounded 
morphology in SRF-depleted cells (Figure 39 A). In addition, treatment with the ROCK inhibitor 
Y27632 was reported to trigger mesenchymal morphology (Gadea et al. 2008), and thus, we 
used it as a control condition to evaluate the phenotypic switch in morphology (Figure 39 A). 
Our data suggest that SRF might play an important role for amoeboid, blebbing mode of cell 
invasion.  
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Figure 39: Cell morphology phenotype is affected in SRF-depleted melanoma cells. (A) Live melanoma 
A375-M2 cells stably co-expressing the nuclear marker H2B-mCherry (red) together with LifeAct-GFP 
(green) treated with control siRNA or siRNA directed against SRF for 72h were plated on 2.5 µg/ml 
Matrigel coated dishes to monitor cell motility and the mode of invasion for a time course of 16h. ROCK 
inhibitor treatment (Y27632, 10 µM), which promotes a mesenchymal elongated morphology, was used 
as a control. Differential interference contrast (DIC) was added for each frame to visualize cell 
morphology. Scale bars, 25 µm. (B) Western blot confirming SRF knockdown efficiency in melanoma A375-
M2 cells. Tubulin served as loading control. 
4.3.2. MRTF-SRF transcription and formin mDia1 regulate amoeboid blebbing 
We next investigated the effects of the SRF transcriptional coactivator, the actin-binding MRTF-
A, on blebbing. Melanoma A375-M2 cells stably expressing LifeAct-GFP (green) were treated 
with siRNA directed against MRTF-A and B (Figure 40 B) and then cultured on top of 2.5 µg/ml 
Matrigel to monitor cell morphology and motility over time. Our results showed an increase in 
elongated mesenchymal morphology in MRTF-A/B-depleted cells and reduced blebbing in the 
absence of MRTF-A/B (Figure 40 A). Similarly, ROCK inhibitor Y27632 treatment resulted in more 
cells showing an elongated phenotype (Figure 40 A).  
Previous findings revealed the importance of the RhoA-mediated formin mDia1 downstream of 
LPAR2 in non-apoptotic plasma membrane blebbing for entotic invasion (Purvanov et al. 2014). 
In this context, recent studies also identified a critical role for another diaphanous-related 
formin, mDia2, in amoeboid blebbing in tumor cells and in the control of the mesenchymal to 
amoeboid morphological transition (Wyse et al. 2017). Hence, we aimed to elucidate whether 
mDia1 affects amoeboid blebbing. For that, mDia1-depleted A375-M2 cells stably expressing 
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LifeAct-GFP (Figure 40 D) were imaged on top of 2.5 µg/ml Matrigel to track cell morphology 
and motility over time. Interestingly, melanoma cells in which mDia1 was silenced appear to 
switch their morphology towards an elongated mesenchymal compared to control cells, which 
predominantly display a rounded blebbing morphology (Figure 40 C).  
 
Figure 40: MRTF/SRF and mDia1 play important roles during amoeboid blebbing. (A) Live A375-M2 cells 
stably expressing LifeAct-GFP to label the actin cytoskeleton transfected with siRNA against control or 
MRTF-A together with MRTF-B for 72h were seeded on top of 2.5 µg/ml Matrigel coated dishes to monitor 
amoeboid blebbing invasion over the time course of 16h. ROCK inhibitor treatment (Y27632, 10 µM) was 
used as control to induce the elongated mesenchymal phenotype. Differential interference contrast (DIC) 
was added for each frame to visualize cell morphology. Scale bars, 25 µm. (B) Western blot demonstrating 
double siRNA knockdown efficiencies for MRTF-A together with MRTF-B in A375-M2 cells stably 
expressing LifeAct-GFP (A375-LA-GFP). Tubulin served as loading control. (C) Live A375-M2 cells stably 
expressing LifeAct-GFP treated with siRNA directed against control, SRF or formin mDia1 for 72h. Cells 
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were plated on Matrigel and analyzed as explained in A. Scale bars, 25 µm. (D) Western blot showing 
siRNA-mediated knockdown efficiencies for SRF and formin mDia1. Tubulin served as loading control.  
 
To evaluate the phenotypic switch, we quantified different parameters including the cell 
roundness using Image J. Quantification of cell roundness was assessed in A375-M2 melanoma 
cells stably expressing LifeAct-GFP seeded on Matrigel for 16h. Our results showed that cell 
roundness was significantly reduced upon depletion of either SRF or MRTF-A/B (Figure 41 A-B), 
suggesting a switch of cell morphology to more elongated cells, which could be explained by the 
Amoeboid to Mesenchymal Transition (AMT). Additionally, the ROCK inhibitor Y27632 served as 
a positive control for the amoeboid to mesenchymal cell morphology transition (Figure 41 A-B) 
(Gadea et al. 2008).  
Another approach was considered in order to determine the amoeboid to mesenchymal 
morphological phenotypic transition by employing a cell impedance assay that allows forces 
during cell adhesion to be measured (Hamidi, Lilja, and Ivaska 2017). Melanoma A375-M2 cells 
silenced with siRNA directed against SRF or control siRNA were treated either with or without 
the ROCK inhibitor Y27632. Subsequently, cells were seeded on top of collagen-coated 96-well 
E-plates to measure cell impedance over time using the xCELLigence system. Cell impedance 
measurements showed a significant increase for control-siRNA cells treated with 10 µM Y27632, 
although cell impedance was not significantly increased for the SRF-depleted cells (Figure 41 C).  
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Figure 41: MRTF/SRF is essential for amoeboid blebbing morphology. (A) Live A375-M2 cells stably 
expressing LifeAct-GFP treated with siRNAs as indicated were seeded on 2.5 µg/ml Matrigel for 16h and 
imaged for further phenotype quantifications. Differential interference contrast (DIC) was used to 
visualize cell morphology. The ROCK inhibitor (Y27632, 10 µM) was applied to siRNA control cells. At least 
six different areas were imaged for each independent experiment and condition. Scale bars, 50 µm. (B) 
Quantification of cell roundness using ImageJ for A375-M2 cells corresponding to A. At least six 
independent experiments were quantified for each condition. Error bars indicate SD. Asterisks indicate 
statistical significance (**, P < 0.01; *** P < 0.001). ns indicates no significance (P ≥ 0.05). (C) Cell 
impedance measurement in melanoma A375-M2 cells. Control or SRF siRNA was transfected 72h before 
seeding on top of 1.7 mg/ml collagen coated E-plates. Cell index was normalized to 0h and impedance 
was recorded over time. 10 µM Y27632 were added to control siRNA-treated cells for the ROCK inhibitor 
condition. 
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Given the novel role of MRTF for non-apoptotic sustained plasma membrane blebbing (Soto 
Hinojosa et al. 2017), as well as our recent results supporting MRTF/SRF for PM blebbing, we 
aimed to examine the subcellular localization of MRTF-A during amoeboid blebbing invasion. 
Thus, A375 melanoma cells stably expressing GFP tagged to full length MRTF-A were imaged on 
a 1.7 mg/ml collagen matrix over time to monitor MRTF-A localization. Our data reveal nuclear 
MRTF-A accumulation in cells moving in an amoeboid blebbing invasion mode (Figure 42 A), 
while in cells moving in a non-blebbing dependent way MRTF-A was localized in the cytoplasm 
(Figure 42 A). These data support the idea that a non-apoptotic blebbing mode of cell motility 
such as amoeboid blebbing requires nuclear MRTF-A translocation, which in turn is crucial to 
promote MRTF/SRF activity via SRF-dependent gene expression. Together these results 
implicate the MRTF/SRF signaling pathway in plasma membrane blebbing.  
 
Figure 42: Amoeboid blebbing triggers nuclear MRTF-A localization. (A) Live melanoma A375-M2 cells 
stably expressing inducible MRTF-A-GFP were induced with doxycycline for 24h and plated on a 1.7 mg/ml 
collagen matrix to monitor MRTF-A subcellular distribution using live cell imaging during amoeboid 
blebbing and compared with non-blebbing cells. Scale bars, 5 µm. 
4.3.3. Molecular regulators are involved in MRTF/SRF-mediated AMT 
Our data until now suggest that the MRTF/SRF signaling pathway is involved during the 
transition from amoeboid blebbing to the elongated mesenchymal morphological phenotype. 
In order to verify this hypothesis, we next characterized which molecular regulators play a role 
for the observed phenotype. Therefore, A375 melanoma cells treated either with control siRNA 
or siRNA directed against SRF for 72h were seeded on Matrigel for 16h followed by RNA 
isolation, we then analyzed the mRNA transcript level of different molecular regulators known 
to be implicated in the amoeboid to mesenchymal transition. In addition, a control condition 
was included, in which non-siRNA transfected cells were treated with the 10 µM ROCK inhibitor 
Y27632. Here, we observed SRF knockdown efficiency in A375 cells (Figure 43 A-B) and 
intriguingly, Integrin β1 expression was slightly increased in SRF-depleted melanoma cells 
(Figure 43 A), which correlates with the observed increase of an elongated-mesenchymal 
phenotype. We also examined another elongated-mesenchymal invasion molecular marker, the 
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Matrix Metalloproteinase-9 (MMP9). MMP9 has been shown to drive mesenchymal invasion 
modes, while its inhibition leads to a switch from mesenchymal mode of migration to rounded 
amoeboid type (Wolf et al. 2003). Remarkably, MMP9 was upregulated in SRF-depleted A375 
cells, but also upon ROCK inhibitor treatment (Figure 43 A) indicating a correlation with the 
mesenchymal mode. We also checked the expression levels of different molecular regulators 
involved in rounded amoeboid migration, for instance Myosin and RhoA. Although RhoA 
transcript levels were unaffected upon SRF depletion, Myosin mRNA expression was slightly 
decreased in SRF-depleted cells (Figure 43 A), pointing towards an increase of actomyosin in 
control cells, in which more amoeboid rounded cells were detected. In contrast, Rac-1 mRNA 
levels, known to be upregulated for the mesenchymal migration, were not altered in the 
absence of SRF (Figure 43 A).  
 
Figure 43: Amoeboid to mesenchymal transition is dependent on MRTF/SRF and actomyosin 
contractility. (A) Relative mRNA levels of SRF, Myosin, Integrin β1, MMP9, RhoA and Rac-1 were assessed 
from melanoma A375-M2 cells treated with siRNA directed against SRF or control for 72h. Cells were 
treated with or without 10 µM Y27632 as indicated and seeded on 2.5 µg/ml Matrigel for 16h followed 
by RNA extraction. Results are shown as the mean from three independent experiments. Error bars 
indicate SD. Asterisks indicate statistical significance (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 
0.0001). ns indicates no significance (P ≥ 0.05). (B) Western blot confirming SRF knockdown efficiency in 
A375 stably expressing LifeAct (LA)-GFP seeded on a matrix. A375-M2 cells were treated as described in 
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A. Rac-1 and pMLC proteins were detected by immunoblotting. Tubulin was used as loading control. (C) 
Western blot band intensities corresponding to B. were quantified from three independent experiments 
using ImageJ. Error bars indicate SD. Asterisks indicate statistical significance (*, P < 0.05; **, P < 0.01). 
These data indicated that SRF depletion is associated with changes in amoeboid to mesenchymal 
morphology which correlate with altered molecular regulators at the transcript level. Thus, we 
further analyzed the impact of regulators at a protein level. These results revealed decreased 
phospho-Myosin (pMLC2) protein levels in SRF-depleted melanoma cells (Figure 43 B-C), but 
also upon 10 µM ROCK inhibitor treatment (Figure 43 B-C), indicating reduced pMLC and 
actomyosin contractility in the absence of SRF, which are associated with less amoeboid 
rounded cells and an increased mesenchymal elongated mode. Consistent with this, Rac-1 
protein levels were upregulated in the absence of SRF and upon ROCK inhibitor treatment 
(Figure 43 B-C), which correlate with the observed morphological phenotype. In conclusion, 
these data provide evidence that MRTF/SRF signaling acts as a molecular mechanism controlling 
the amoeboid to mesenchymal phenotypic transition.  
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5. Discussion 
5.1. Effects of MRTF/SRF on plasma membrane blebbing 
Besides the changes in actin cytoskeletal dynamics and gene expression mediated by MRTF/SRF 
(E. N. Olson and Nordheim 2010), the SRF transcription factor together with its coactivator 
MRTF-A have also been reported to play a role in cell proliferation, motility and migration 
(Medjkane et al. 2009). Interestingly, depletion of MRTF-A or SRF in invasive cells leads to 
downregulation of cytoskeletal target genes required for actomyosin contractility, and also 
implicated in tumor cell invasion (Medjkane et al. 2009).  
Several studies have provided evidence that SRF acts as a key regulator of cytoskeletal target 
gene expression, which is also controlled by the MRTFs and Rho-actin-signaling (Esnault et al. 
2014). The importance of SRF for several cell functions has been identified. For instance, SRF 
knockdown affects actin cytoskeleton organization and inhibits expression of genes related to 
actin cytoskeleton homeostasis (Sun et al. 2006). Consistent with this, SRF and MRTF-loss of 
function phenotypes displayed defects in myogenesis and migration (Pipes, Creemers, and Olson 
2006). Similarly, SRF-depleted embryonic stem cells had actin cytoskeleton organization defects 
that in turn impaired cell spreading, adhesion and migration (Schratt et al. 2002).  
Therefore, given the association between the MRTF/SRF signaling pathway and the contractile 
actin cytoskeleton, we first evaluated the effects of MRTF/SRF on sustained plasma membrane 
blebbing. Blebs are actin-rich membrane protrusions essential for cell motility processes, and 
which are highly regulated by actin cytoskeleton dynamics and actomyosin contractility forces 
(Fackler and Grosse 2008). Notably, our data show that suppression of SRF affects plasma 
membrane blebbing, specifically bleb retraction (Figure 22). In this context, previous studies 
have shown that bleb retraction requires the recruitment of ERM proteins and actomyosin 
contractility (Guillaume T Charras et al. 2006). Thus, our results reveal that dynamic bleb 
retraction is controlled by the MRTF/SRF transcriptional pathway. In addition, other actin cell 
cortex proteins may contribute to the plasma membrane tension necessary for efficient bleb 
expansion and retraction. 
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Several studies have suggested the importance of different formins for blebbing, such as FHOD1, 
FMNL2, DIAPH3 and mDia1 (Thomas M Kitzing et al. 2007; Hannemann et al. 2008; T M Kitzing 
et al. 2010; Stastna et al. 2012; Bovellan et al. 2014). Recent findings reported the critical role of 
the actin nucleator formin mDia1 in plasma membrane blebbing (Bovellan et al. 2014) and 
subsequent entotic invasion (Purvanov et al. 2014). Hence, we further analyzed whether formin 
mDia1 expression is affected in SRF-depleted cells. Even though depletion of mDia1 was shown 
to reduce bleb activity (Purvanov et al. 2014) and resulted in larger blebs (Bovellan et al. 2014), 
expression levels of formin mDia1 were not altered in the absence of SRF (Figure 30), in which 
blebbing activity was also decreased (Figure 22). These data indicate that the MRTF/SRF 
transcriptional pathway has no effect on formin mDia1 expression during non-apoptotic plasma 
membrane blebbing. 
Although SRF is a target gene of its own transcriptional activity (Esnault et al. 2014), our studies 
between induced non-apoptotic plasma membrane blebbing and MRTF/SRF transcription 
revealed a direct association, in which sustained long-term blebbing enhances MRTF/SRF activity 
(Figure 26). Our findings show that during dynamic plasma membrane blebbing MRTF/SRF 
transcription is regulated by the contractile actin cortex. 
5.2. Cortical blebbing controls subcellular localization and nucleocytoplasmic 
translocation of MRTF-A  
Several triggers such as mechanical stress, serum, LPA or formins can induce MRTF-A nuclear 
accumulation (Baarlink, Wang, and Grosse 2013). In this study, we hypothesized that dynamic 
blebbing, known to be regulated by the contractile actin cytoskeleton (Guillaume T Charras et 
al. 2006), could lead to changes in the G-/F-actin ratio resulting in nuclear shuttling of MRTF-A. 
Consistent with our findings demonstrating the relevance of the SRF transcription factor for non-
apoptotic PM blebbing, we next tested the functional significance of the SRF coactivator MRTF-
A during induced blebbing. Surprisingly, we found a striking correlation between induced non-
apoptotic blebbing and dynamic nucleocytoplasmic shuttling of the actin-binding protein MRTF-
A. Here, in blebbing cells MRTF-A is located in the nucleus, while in non-blebbing cells MRTF-A 
is located predominantly in the cytoplasm (Figure 24, Figure 44). Thus, our data suggest that 
cortical contractility is important for nuclear translocation of MRTF-A.  
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In addition to sustained blebbing activity triggering nuclear MRTF-A accumulation and therefore 
enhancing MRTF/SRF transcription, we next examined whether there is a direct link between 
MRTF-A localization and the contractile actin cortex during induced PM blebbing by blocking 
blebbing activity. Indeed, Blebbistatin treatment resulted in MRTF-A export to the cytoplasm 
(Figure 25), suggesting that sustained and induced PM blebbing together with the associated 
contractile actin cortex regulate the subcellular localization and nucleocytoplasmic shuttling of 
MRTF-A. Although several triggers are known to induce actin polymerization leading to nuclear 
MRTF-A accumulation (Baarlink, Wang, and Grosse 2013), our work reveals cortical blebbing as 
a novel trigger that controls the subcellular localization of MRTF-A (Figure 44). 
 
Figure 44: Plasma membrane blebbing is tightly coupled to dynamic actin-driven MRTF-A 
nucleocytoplasmic shuttling. 
5.3. Ezrin as a regulator of MRTF/SRF-dependent transcription 
Previous studies have reported the involvement of the Rho-ROCK pathway and the recruitment 
of ERM proteins, in particular Ezrin, together with actin in the reassembly of the contractile actin 
cortex during bleb retraction (Guillaume T Charras et al. 2006). In this thesis, ERM proteins and 
different actin-related proteins were examined as potential target genes. It is noteworthy that 
our results reveal that Ezrin expression is upregulated upon induced continuous non-apoptotic 
blebbing on a protein as well as transcript level (Figure 27). Although Ezrin, Radixin and Moesin 
are highly homologous, they are implicated in different cellular functions. Therefore, we 
assessed the involvement of other ERMs and myosin in order to understand whether ERMs or 
myosin, which are known to play important roles during blebbing, are regulated in a similar 
manner to Ezrin, or whether Ezrin is specifically upregulated in response to induced long-term 
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blebbing. Interestingly, our data showed that induced PM blebbing leads to upregulation of the 
specific ERM Ezrin, whereas Radixin, Moesin and Myosin were unaffected (Figure 27), suggesting 
a specificity for Ezrin induction in response to blebbing activity. This is consistent with recent 
work that reported the relevance of Ezrin phosphorylation by ROCK for the recruitment of 
Epidermal growth factor receptor kinase substrate 8 (Eps8) to the plasma membrane. This is 
required for reassembly of the actin cortex and efficient bleb retraction (Ikenouchi and Aoki 
2017; Aoki et al. 2016).  
Besides the regulation of target genes related to proliferation, contractility or ECM remodelling 
by MRTF/SRF (Esnault et al. 2014; Gualdrini et al. 2016), our identification of targets implicated 
during induced long-term PM blebbing mediated by the MRTF/SRF pathway was crucial to 
further understand this mechanism driving blebbing and subsequent entotic invasion. Notably, 
induction of Ezrin was significantly reduced in the absence of either SRF or MRTF-A/B during 
induced PM blebbing (Figure 27). In contrast, expression levels of other ERMs were unaffected 
upon suppression of SRF (Figure 27), indicating that these proteins are not controlled by the 
MRTF/SRF pathway upon induced blebbing activity. Consistent with our results where Ezrin is 
upregulated in a MRTF/SRF-dependent manner, Ezrin specificity was further confirmed using 
the prototypic serum stimulation assay known to induce the MRTF/SRF pathway (Figure 28) 
(Baarlink, Wang, and Grosse 2013; Vartiainen et al. 2007).  
Furthermore, several triggers have been identified that induce blebbing for bleb-associated 
migration, for instance increase of cortical contractility forces, cell physical confinement and low 
adhesion to the extracellular matrix (Martin Bergert et al. 2015; Ruprecht et al. 2015; Liu et al. 
2015). Hence, we confirmed that our model of induced blebbing by matrix deadhesion is 
sufficient to trigger PM blebbing. As a result of pharmacological interference with blebbing, Ezrin 
and SRF upregulation were inhibited upon conditions of low adhesion (Figure 29). This validates 
our model and hypothesis, in which preventing attachment leads to cortical blebbing.  
A recent study showed that bleb expansion requires Rnd3 recruitment, whereas bleb retraction 
is mediated by RhoA and ROCK phosphorylation that leads to Rnd3 inactivation and subsequent 
Ezrin activation (Aoki et al. 2016). In addition, this study reported that Ezrin and Eps8 are 
essential regulators of actin reassembly for blebbing dynamics (Aoki et al. 2016). This is 
consistent with our data, in which Ezrin is recruited to the plasma membrane to reassemble the 
actin cortex and therefore is upregulated during sustained blebbing activity. Moreover, our 
results point a critical role for Ezrin as a MRTF/SRF-dependent target gene in the regulation of 
induced cortical blebbing and suggesting a role in bleb-associated invasion. 
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5.4. The importance of MRTF/SRF transcription and Ezrin for entotic invasion 
Our data demonstrate that Ezrin upregulation via the MRTF/SRF transcriptional pathway 
controls dynamic PM blebbing. To further explore this process, we tested the impact of 
MRTF/SRF transcription and Ezrin on bleb-associated entotic invasion. Remarkably, analysis of 
Ezrin subcellular localization during cell-in-cell invasion revealed that Ezrin is redistributed and 
polarized in the invading cell (Figure 21 and Figure 31), which in turn requires sustained actin-
driven PM blebbing (Purvanov et al. 2014). 
Given the fundamental role of Ezrin during entotic invasion, we focused on the phosphorylation 
of the ERM Ezrin, which is an essential process known to regulate its activation. Herein, we 
examined the activation state of this actin-membrane linker during the entotic process by 
analyzing its phosphorylation state. We observed that endogenous phosphorylated-ERM 
colocalizes with Ezrin and actin during entotic invasion at advanced stages (Figure 31) showing 
a polarized enrichment of pERM at the rear of the invading cell. These findings reveal the 
importance of Ezrin phosphorylation during entotic invasion, in which the actin cytoskeleton-
plasma membrane linker Ezrin is found polarized and highly enriched during cell-in-cell invasion. 
These data are consistent with the idea that invading cells display polarized Ezrin and actin 
enrichment at the rear, which provides actomyosin contractility to generate the force to invade 
the host cell. Similarly, cell motility in migrating cells is mediated by the formation of actin-rich 
protrusions dependent on actomyosin contractile forces at the rear end of the invading cell (G. 
Charras and Paluch 2008). Accordingly, the driving force is generated by the actin-rich bleb 
structures, while the direction of movement is defined by the Ezrin-rich uropod-like structure 
(ERULS) at the rear of amoeboid blebbing cells (Lorentzen et al. 2011).  
Even though entosis is a long-term process, whether transcriptional activity regulates entotic 
invasion was unknown. Thus, we aimed to examine the impact of transcriptional activity on 
entosis by interfering with global transcription. Interestingly, our data showed that entosis 
ability was strongly reduced by inhibiting transcription (Figure 32), suggesting that global 
transcription is necessary for entotic invasion. In a similar manner, translation inhibition by 
blocking protein synthesis led to inhibition of entosis (Figure 32), indicating the crucial role of 
global transcription and translation for efficient entotic invasion.  
Previous studies have reported that the MRTF/SRF transcriptional pathway plays an important 
role during tumor invasion. For instance, several studies have revealed the relevance of MRTF-
A during invasive migration (Brandt et al. 2009; Medjkane et al. 2009). Depletion of SRF or MRTF-
A/B reduces cell adhesion, and the spread and invasiveness of tumor cells (Medjkane et al. 
2009). In contrast, the expression of constitutively active SRF enhances the formation of liver 
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nodules, which promotes hepatocellular carcinoma (Ohrnberger et al. 2015). In this work, we 
examined the importance of MRTF/SRF transcription for bleb-associated entotic invasion. It is 
noteworthy that suppression of either the ERM Ezrin, SRF or simultaneous depletion of MRTF-A 
and MRTF-B, significantly reduced entosis ability, although to a much more moderate degree 
than in the absence of SRF (Figure 33). Similarly, Ezrin knockdown inhibited the invasion of 
melanoma cells (Lorentzen et al. 2011). Consistent with this, we show that expression of 
constitutively active MRTF-A promotes entotic invasion (Figure 34). These data provide support 
that not only global transcription, but also the specific MRTF/SRF transcriptional pathway and 
our recently identified target gene Ezrin are required for efficient entotic invasion. In addition, 
given the mutual dependence between the MRTF/SRF and the YAP-TAZ signaling pathways in 
controlling cell contractility and TGFβ-signaling in cancer-associated fibroblasts (Foster, 
Gualdrini, and Treisman 2018), it would be interesting to further test whether the YAP-TAZ 
pathway is involved for blebbing and entotic invasion. 
Consistent with the importance of MRTF/SRF transcription for entosis, SRF depletion in the 
invading cell remarkably reduced entosis, whereas knockdown of SRF in the host cell had no 
effect (Figure 35). In turn, SRF appears to be specifically necessary in the actively invading cell 
to promote entotic invasion. Notably, SRF-depleted cells fail to successfully complete entotic 
invasion (Figure 35), suggesting that the invading cell, which showed extensive blebbing before 
cell engulfment, fails to produce enough mechanical force to invade into the host cell due to 
disrupted bleb dynamics in the absence of SRF. In this context, recent studies showed that 
actomyosin contractility and cell stiffness are essential forces driving entosis (Sun, Luo, et al. 
2014). Furthermore, focusing on the SRF transcriptional coactivator MRTF-A subcellular 
localization during entotic invasion, we identified a nuclear MRTF-A accumulation in the actively 
invading cells before cell engulfment to initiate entotic invasion (Figure 36). Together, these data 
indicate that the actin-controlled MRTF/SRF pathway is fundamental in entosis, providing the 
driving force for blebbing and subsequent entotic invasion at the invading cells. These findings 
also highlight the role of MRTF/SRF in cell-in-cell invasion involving expression of Ezrin.  
Although the physiological consequences of entosis are not yet well known, some evidence 
supports entosis as a tumor-suppressive mechanism to clear dysfunctional cells after non-
apoptotic death of the internalized entotic cell (Florey et al. 2011). Whereas other studies 
revealed that entosis triggers aneuploidy due to failed cytokinesis in the host cell thus enhancing 
tumor progression (Matej Krajcovic et al. 2011). In addition to the prevalence of entosis in 
cancer, LPA and LPAR2, which are key regulators of entosis (Purvanov et al. 2014), are also 
known to play a role during cancer metastasis (Choi et al. 2010), suggesting a correlation 
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between entosis and malignancy. Further studies are required to investigate the therapeutic 
clinical potential of entosis in cancer.  
5.5. Functional significance of Ezrin expression for bleb dynamics and entosis 
Several studies have identified Ezrin as a novel regulator of invasion and metastasis (Lorentzen 
et al. 2011; Y. Yu et al. 2004; Ren et al. 2009). Additionally, Ezrin is involved in amoeboid blebbing 
driving cell motility (Lorentzen et al. 2011). Consistent with the correlation between blebbing 
and Ezrin, increased activity of the ERMs is associated with reduced blebbing in different cell 
types such as melanoma cells, mast cells and zebrafish primordial germ cells (Goudarzi et al. 
2012; Yanase et al. 2011; Lorentzen et al. 2011). In contrast to previous studies, which have 
observed a negative regulation between the ERMs and blebbing activity, we uncovered a 
positive feedback loop to sustain PM blebbing activity by Ezrin upregulation. Hence, given that 
induction of Ezrin expression depends on MRTF/SRF and PM blebbing, we further focused on 
the significance of Ezrin in this phenotype. Therefore, we stably expressed our identified MRTF-
SRF target gene, wild-type Ezrin, and examined bleb dynamics compared to the control GFP-
expressing cells upon suppression of SRF. These data demonstrate that wild-type Ezrin 
expression is sufficient to restore efficient bleb dynamics in the absence of SRF (Figure 37). In 
contrast, GFP-expressing cells in which SRF was depleted fail to produce dynamic blebbing, 
indicating the functional relevance of Ezrin re-expression to rescue defective bleb retraction in 
response to SRF suppression. These findings are consistent with the essential function of Ezrin 
in the reassembly of the contractile actin cortex during bleb retraction mediated by actomyosin 
contractility (Guillaume T Charras et al. 2006). As a consequence of the restored plasma 
membrane blebbing, expression of wild-type Ezrin is necessary and sufficient to rescue entotic 
invasion in the absence of SRF, whereas entosis was impaired in control cells expressing GFP 
upon SRF depletion (Figure 38). In turn, these data support Ezrin as a MRTF/SRF target gene 
controlling bleb dynamics and entosis.  
Furthermore, we analyzed the impact of the non-phosphorylatable Ezrin mutant form, Ezrin-
T567A (TA), on bleb dynamics and subsequent entosis. This inactive mutant fails to link the 
plasma membrane to the underlying actin cytoskeleton (Gautreau, Louvard, and Arpin 2000). 
However, expression of the TA mutant, which does not block blebbing activity, has no effect on 
amoeboid invasion in melanoma cells (Lorentzen et al. 2011). Alternatively, expression of the 
phosphomimetic Ezrin T567D, which acts as a constitutively active form, robustly inhibits 
blebbing activity leading to significantly reduced amoeboid invasion (Guillaume T Charras et al. 
2006; Lorentzen et al. 2011). Consistently, our data reveal that expression of the non-
phosphorylatable Ezrin mutant triggers non-functional bleb dynamics and less blebbing activity 
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resulting in reduced entotic invasion (Figure 37 and Figure 38). Ezrin T567A fails to link the PM 
to the actin cytoskeleton (Gautreau, Louvard, and Arpin 2000), which explains the importance 
of phosphorylation for efficient Ezrin activation and dynamic blebbing. Taken together, our 
results report that MRTF/SRF-dependent upregulation of Ezrin is critical for sustained PM 
blebbing to promote entosis. 
5.6. Role of the MRTF/SRF pathway on amoeboid to mesenchymal transition 
Given the association between the actin-regulated MRTF/SRF transcriptional feedback and non-
apoptotic blebbing for subsequent entotic invasion, we next focused on another bleb-associated 
motility mode, amoeboid blebbing, to further investigate the impact of the MRTF/SRF 
transcriptional pathway. Amoeboid blebbing is often observed during cancer invasion, in which 
cells are characterized by rounded blebbing morphology, fast migration, low adhesion and high 
cortical actomyosin contractility (Sahai and Marshall 2003; Sanz-Moreno et al. 2008). 
Interestingly, amoeboid blebbing invasion bears similarities with entotic invasion, both being 
regulated by the actin cytoskeleton, Rho-ROCK signaling and actomyosin forces. Our results 
reveal the importance of the MRTF/SRF pathway for amoeboid blebbing, suggesting a cell 
morphology switch in response to either MRTF-A/B or SRF depletion, triggering the amoeboid 
to mesenchymal transition (AMT) (Figure 41). 
In addition to the relevance of MRTF/SRF transcription for invasive cell migration, this pathway 
controls expression of target genes involved in cell contractility and extracellular matrix 
remodelling (Gualdrini et al. 2016). Here, we show that amoeboid blebbing is dependent on the 
MRTF/SRF transcriptional pathway and actomyosin contractility (Figure 43). In turn, we 
confirmed that SRF-depleted cells undergo mesenchymal morphology leading to upregulation 
of previously described target genes related to actomyosin contractility (Figure 4) (Gadea et al. 
2008; Wolf et al. 2003). In contrast to amoeboid to mesenchymal transition, recent studies 
reported that cortical contractility and low adhesion conditions trigger mesenchymal to 
amoeboid motility transition (MAT) in confined 3D environments (Ruprecht et al. 2015; Liu et al. 
2015). Further studies are required to characterize the molecular mechanisms driving AMT and 
MAT. Therefore, it remains a future challenge to identify the mechanism and target genes, that 
are responsible for regulating MRTF/SRF transcription in amoeboid blebbing invasion and its 
transition to the mesenchymal elongated invasion. 
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5.7. Conclusion 
The work presented in this thesis is focused on the transcriptional regulation of the actin-
mediated MRTF/SRF pathway and its role in blebbing and bleb-associated invasion. In this study, 
we demonstrate that bleb dynamics and efficient entosis require MRTF/SRF transcriptional 
activity mediated by upregulation of the metastasis-associated ERM protein Ezrin (Figure 45). 
Consistent with the importance of the MRTF/SRF pathway for sustained blebbing, we find that 
cortical plasma membrane blebbing regulates dynamic MRTF-A nuclear translocation (Figure 44) 
to enhance SRF transcriptional activity necessary for entotic invasion. Our findings reveal Ezrin 
as an MRTF/SRF target gene to promote bleb-associated cell-in-cell invasion. Our results 
highlight the importance of transcriptional feed forward signaling for bleb-associated invasive 
motility and entosis. Thereby, this study opens new avenues providing a transcriptional 
regulation feed forward loop controlling bleb-associated motility. 
 
Figure 45: Schematic model of this work. This cartoon shows actin-regulated MRTF/SRF-mediated 
upregulation of Ezrin and actomyosin contractility, which are critical for sustained bleb dynamics. 
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